This is a preview of subscription content, log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
Abbreviations
- ATP:
-
adenosine triphosphate
- COMT:
-
catechol-O-methyltransferase
- cyclic AMP:
-
cyclic adenosine 3′,5′-monophosphate
- cyclic GMP:
-
cyclic guanosine 3′,5′-monophosphate
- DMPP:
-
1, I-dimethyl-4-phenylpiperazinium iodide
- DOPEG:
-
3,4-dihydroxy-phenylglycol
- e.j.p.:
-
excitatory junction potential
- MAO:
-
monoamine oxidase
- PGA2, PGB2, PGE1, PGE2, PGF1α, PGF2α :
-
The respective prostaglandins
References
Abdel-Aziz, A.: Blockade by prostaglandins E2 and F1α of the response of the rabbit ileum to stimulation of sympathetic nerve and its reversal by some antihistamines, dexamphetamine and methylphenidate. Europ. J. Pharmacol. 25, 226–230 (1974)
Åblad, B., Ek, L., Johansson, B., Waldeck, B.: Inhibitory effect of propranolol on the vasoconstrictor response to sympathetic nerve stimulation. J. Pharm. Pharmacol. 22, 627–628 (1970)
Ackerly, J., Blumberg, A., Peach, M.: Angiotensin interactions with myocardial sympathetic neurons: Enhanced release of dopamine-β-hydroxylase during nerve stimulation. Proc. Soc. exp. Biol. (N.Y.) 151, 650–653 (1976)
Adler-Graschinsky, E., Langer, S.Z.: Possible role of a β-adrenoceptor in the regulation of noradrenaline release by nerve stimulation through a positive feed-back mechanism. Brit. J. Pharmacol. 53, 43–50 (1975)
Allen, G.S., Glover, A.B., McCulloch, M.W., Rand, M.J., Story, D.F.: Modulation by acetylcholine of adrenergic transmission in the rabbit ear artery. Brit. J. Pharmacol. 54, 49–53 (1975)
Allen, G.S., Glover, A.B., Rand, M.J., Story, D.F.: Effects of acetylcholine on vasoconstriction and release of 3H-noradrenaline in response to sympathetic nerve stimulation in the isolated artery of the rabbit ear. Brit. J. Pharmacol. 46, 527–528P (1972a)
Allen, G.S., Rand, M.J., Story, D.F.: Effects of McN-A-343 and DMPP on the uptake and release of 3H-noradrenaline by guinea-pig atria. Brit. J. Pharmacol. 45, 480–489 (1972b)
Allen, G.S., Rand, M.J., Story, D.F.: Comparison of effects of six cholinomimetic drugs on inhibition of uptake of 3H-(±)-noradrenaline by guinea-pig atria. Brit. J. Pharmacol. 47, 179–180 (1973)
Allen, G.S., Rand, M.J., Story, D.F.: Effects of the muscarinic agonist McN-A-343 on the release by sympathetic nerve stimulation of (3H)-noradrenaline from rabbit isolated ear arteries and guinea-pig atria. Brit. J. Pharmacol. 51, 29–34 (1974)
Ambache, N., Dunk, L.P., Verney, J., Zar, M.A.: Inhibition of post-ganglionic motor transmission in the vas deferens by indirectly acting sympathomimetic drugs. J. Physiol. (Lond.) 227, 433–456 (1972)
Ambache, N., Killick, S.W., Srinivasan, V., Zar, M.A.: Effects of lysergic acid diethylamide on autonomic post-ganglionic transmission. J. Physiol. (Lond.) 246, 571–593 (1975)
Ambache, N., Zar, M.A.: Evidence against adrenergic motor transmission in the guinea-pig vas deferens. J. Physiol. (Lond.) 216, 359–389 (1971)
Andén, N.E., Corrodi, H., Fuxe, K., Hökfelt, B., Hökfelt, T., Rydin, C., Svensson, T.: Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci. 9, I, 513–523 (1970)
Andén, N.E., Grabowska, M., Strömbom, U.: Different alpha-adrenoceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents. Naunyn-Schmiedeberg's Arch. Pharmacol. 292, 43–52 (1976)
Anderson, T.R., Slotkin, T.A.: Effects of morphine on the rat adrenal medulla. Biochem. Pharmacol. 24, 671–679 (1975)
Anderson, T.R., Slotkin, T.A.: The role of neural input in the effects of morphine on the rat adrenal medulla. Biochem. Pharmacol. 25, 1071–1074 (1976)
Antonaccio, M.J., Halley, J., Kerwin, L.: Functional significance of α-stimulation and α-blockade on responses to cardiac nerve stimulation in anesthetized dogs. Life Sci. 15, 765–777 (1974)
Armstrong, J.M., Boura, A.L.A.: Effects of clonidine and guanethidine on peripheral sympathetic nerve function in the pithed rat. Brit. J. Pharmacol. 47, 850–852 (1973)
Bacq, Z.M., Fredericq, H.: Recherches sur la physiologie et la pharmacologie du système nerveux autonome. XIV. — Modifications apportées par deux dérivés de l'aminométhylbenzodioxane (883F. et 933F.) aux effets de l'adrénaline et de l'excitation sympathique sur la membrane nictitante du chat. Arch. int. Physiol. 40, 454–466 (1935)
Baldessarini, R.J.: Release of catecholamines. In: Iversen, L.L., Iversen, S.D., Snyder, S.H. (eds.), Handbook of Psychopharmacology, Vol. 3, pp. 37–137. New York-London: Plenum Press 1975
Balfour, D.J.K.: Effects of nicotine on the uptake and retention of 14C-noradrenaline and 14C-5-hydroxytryptamine by rat brain homogenates. Europ. J. Pharmacol. 23, 19–26 (1973)
Barrett, A.M., Nunn, B.: Adrenergic neuron blocking properties of (±)-propranolol and (+)-propranolol. J. Pharm. Pharmacol. 22, 806–810 (1970)
Barth, C.: Aktivität der Catechol-ortho-methyltransferase unter Angiotensineinfluß und beim DOCA-Hochdruck der Ratte. Z. klin. Chem. 8, 379–382 (1970)
Baum, T., Shropshire, A.T.: Influence of prostaglandins on autonomic responses. Amer. J. Physiol. 221, 1470–1475 (1971)
Bedwani, J.R., Millar, G.C.: Prostaglandin release from cat and dog spleen. Brit. J. Pharmacol. 54, 499–505 (1975)
Beleslin, D., Polak, R.L.: Depression by morphine and chloralose of acetylcholine release from the cat's brain. J. Physiol. (Lond.) 177, 411–419 (1965)
Bell, C.: Differential effects of tetrodotoxin on sympathomimetic actions of nicotine and tyramine. Brit. J. Pharmacol. 32, 96–103 (1968)
Bell, C.: Mechanism of enhancement by angiotensin II of sympathetic adrenergic transmission in the guinea pig. Circulat. Res. 31, 348–355 (1972)
Bell, C.: Release of endogenous noradrenaline from an isolated elastic artery. J. Physiol. (Lond.) 236, 473–482 (1974)
Bell, C., Conway, E.L., Lang, W.J., Padanyi, R.: Vascular dopamine receptors in the canine hindlimb. Brit. J. Pharmacol. 55, 167–172 (1975)
Bell, C., Vogt, M.: Release of endogenous noradrenaline from an isolated muscular artery. J. Physiol. (Lond.) 215, 509–520 (1971)
Bell, K.M., Rees, J.M.H.: The depressant action of morphine on transmission at a skeletal neuromuscular junction is non-specific. J. Pharm. Pharmacol. 26, 686–691 (1974)
Benelli, G., Bella, D.D., Gandini, A.: Angiotensin and peripheral sympathetic nerve activity. Brit. J. Pharmacol. 22, 211–219 (1964)
Bennett, M.R.: An electrophysiological analysis of the storage and release of noradrenaline at sympathetic nerve terminals. J. Physiol. (Lond.) 229, 515–531 (1973a)
Bennett, M.R.: An electrophysiological analysis of the uptake of noradrenaline at sympathetic nerve terminals. J. Physiol. (Lond.) 229, 533–546 (1973b)
Bennett, M.R., Florin, T.: An electrophysiological analysis of the effect of Ca ions on neuromuscular transmission in the mouse vas deferens. Brit. J. Pharmacol. 55, 97–104 (1975)
Bennett, M.R., Middleton, J.: An electrophysiological analysis of the effects of reserpine on adrenergic neuromuscular transmission. Brit. J. Pharmacol. 55, 79–85 (1975a)
Bennett, M.R., Middleton, J.: An electrophysiological analysis of the effects of amine-uptake blockers and β-adrenoceptor blockers on adrenergic neuromuscular transmission. Brit. J. Pharmacol. 55, 87–95 (1975b)
Bentley, G.A., Li, D.M.F.: Studies of the new hypotensive drug ST 155. Europ. J. Pharmacol. 4, 124–134 (1968)
Bergström, S., Farnebo, L.O., Fuxe, K.: Effect of prostaglandin E2 on central and peripheral catecholamine neurons. Europ. J. Pharmacol. 21, 362–368 (1973)
Berkowitz, B.A., Spector, S.: Effect of caffeine and theophylline on peripheral catecholamines. Europ. J. Pharmacol. 13, 193–196 (1971)
Bevan, J.A., Haeusler, G.: Electrical events associated with the action of nicotine at the adrenergic nerve terminal. Arch. int. Pharmacodyn. 218, 84–95 (1975)
Bevan, J.A., Su, C.: Distribution theory of resistance of neurogenic vasoconstriction to alpha-receptor blockade in the rabbit. Circulat. Res. 28, 179–187 (1971)
Bevan, J.A., Su, C.: Uptake of nicotine by the sympathetic nerve terminals in the blood vessel. J. Pharmacol. exp. Ther. 182, 419–426 (1972)
Bevan, R.D., Purdy, R.E., Su, C., Bevan, J.A.: Evidence for an increase in adrenergic nerve function in blood vessels from experimental hypertensive rabbits. Circulat. Res. 37, 503–508 (1975)
Bhagat, B., Dhalla, N.S., Ginn, D., Montagne, A.E., Montier, A.D.: Modification by prostaglandin E2 (PGE2) of the response of guinea-pig isolated vasa deferentia and atria to adrenergic stimuli. Brit. J. Pharmacol. 44, 689–698 (1972)
Bhagat, B., Robinson, I.M., West, W.L.: Mechanism of sympathomimetic responses of isolated guinea-pig atria to nicotine and dimethylphenylpiperazinium iodide. Brit. J. Pharmacol. 30, 470–477 (1967)
Blakeley, A.G.H., Brown, L., Dearnaley, D.P., Woods, R.I.: Perfusion of the spleen with blood containing prostaglandin E1: transmitter liberation and uptake. Proc. roy. Soc. B 174, 281–292 (1969a)
Blakeley, A.G.H., Brown, G.L., Ferry, C.B.: Pharmacological experiments on the release of the sympathetic transmitter. J. Physiol. (Lond.) 167, 505–514 (1963)
Blakeley, A.G.H., Brown, L., Geffen, L.B.: Uptake and re-use of sympathetic transmitter in the cat's spleen. Proc. roy. Soc. B 174, 51–68 (1969b)
Blakeley, A.G.H., Powis, G., Summers, R.J.: Uptake of (L)-noradrenaline in the isolated cat heart perfused with blood containing desmethylimiprarnine (DMI) and 17-β-oestradiol (17βO). J. Physiol. (Lond.) 234, 108–109P (1973)
Blakeley, A.G.H., Powis, G., Summers, R.J.: An uptake mechanism for L-noradrenaline in the cat spleen, associated with the nerves but distinct from uptake1 J. Physiol. (Lond.) 238, 193–206 (1974)
Blaustein, M.P., Johnson, E.M., Needleman, P.: Calcium-dependent norepinephrine release from presynaptic nerve endings in vitro. Proc. nat. Acad. Sci. (Wash.) 69, 2237–2240 (1972)
Bloom, F.E.: Amine receptors in CNS. I. Norepinephrine. In: Iversen, L.L., Iversen, S.D., Snyder, S.H. (eds.), Handbook of Psychopharmacology, Vol. 6, pp. 1–22. New York-London: Plenum Press 1975
Blosser, J.C., Catravas, G.N.: Action of reserpine in morphine-tolerant rats: Absence of an antagonism of catecholamine depletion. J. Pharmacol. exp. Ther. 191, 284–289 (1974)
Blumberg, A.L., Ackerly, J.A., Peach, M.J.: Differentiation of neurogenic and myocardial angiotensin II receptors in isolated rabbit atria. Circulat. Res. 36, 719–726 (1975a)
Blumberg, A., Brooker, G., Peach, M., Westfall, T.C.: Angiotensin interactions with myocardial sympathetic neurons: Increased release of dopamine-β-hydroxylase and elevated atrial cyclic AMP concentrations. Fed. Proc. 34, 770 Abs (1975b)
Boadle, M.C., Hughes, J., Roth, R.H.: Angiotensin accelerates catecholamine biosynthesis in sympathetically innervated tissues. Nature (Lond.) 222, 987–988 (1969)
Boadle-Biber, M.C., Hughes, J., Roth, R.H.: Acceleration of catecholamine biosynthesis in sympathetically innervated tissues by angiotensin-II-amide. Brit. J. Pharmacol. 46, 289–299 (1972)
Bogaievsky, D., Bogaievsky, Y., Tsoucaris-Kupfer, D., Schmitt, H.: Blockade of the central hypotensive effect of clonidine by α-adrenoreceptor antagonists in rats, rabbits and dogs. Clin. exp. Pharmacol. Physiol. 1, 527–534 (1974)
Boissier, J.R., Giudicelli, J.F., Fichelle, J., Schmitt, H., Schmitt, H.: Cardiovascular effects of 2-(2, 6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155). Europ. J. Pharmacol. 2, 333–339 (1968)
Bolme, P., Corrodi, H., Fuxe, K., Hökfelt, T., Lidbrink, P., Goldstein, M.: Possible involvement of central adrenaline neurons in vasomotor and respiratory control. Studies with clonidine and its interactions with piperoxane and yohimbine. Europ. J. Pharmacol. 28, 89–94 (1974)
Boonyaviroj, P., Gutman, Y.: α-Adrenergic stimulants, prostaglandins and catecholamine release from the adrenal gland in vitro. Prostaglandins 10, 109–116 (1975)
Borowski, E., Ehrl, H., Starke, K.: Relative pre-and postsynaptic potencies of α-adrenolytic drugs. Naunyn-Schmiedeberg's Arch. Pharmacol. 293, R2 (1976)
Bolting, J.H., Salzmann, R.: The effect of indomethacin on the release of prostaglandin E2 and acetylcholine from guinea-pig isolated ileum at rest and during field stimulation. Brit. J. Pharmacol. 50, 119–124 (1974)
Boullin, D.J., Costa, E., Brodie, B.B.: Evidence that blockade of adrenergic receptors causes overflow of norepinephrine in cat's colon after nerve stimulation. J. Pharmacol. exp. Ther. 157, 125–134 (1967)
Boykin, M.E., Martin, R.H.: Preliminary observations on the uptake of catecholamines in synaptosomes of opiate-treated animals. J. Pharm. Pharmacol. 25, 484–485 (1973)
Braestrup, C., Nielsen, M.: Intra-and extraneuronal formation of the two major noradrenaline metabolites in the cns of rats. J. Pharm. Pharmacol. 27, 413–419 (1975)
Brandão, F., Guimarães, S.: Inactivation of endogenous noradrenaline released by electrical stimulation in vitro of dog saphenous vein. Blood Vessels 11, 45–54 (1974)
Brandon, K.W., Boyd, H.: Release of noradrenaline from the spleen of the cat by acetylcholine. Nature (Lond.) 192, 880–881 (1961)
Brink, F.G. van den: The model of functional interaction. I. Development and first check of a new model of functional synergism and antagonism. Europ. J. Pharmacol. 22, 270–278 (1973)
Brody, M.J., Kadowitz, P.J.: Prostaglandins as modulators of the autonomic nervous system. Fed. Proc. 33, 48–60 (1974)
Brown, G.L.: The release and fate of the transmitter liberated by adrenergic nerves. Proc. roy. Soc. B 162, 1–19 (1965)
Brown, G.L., Davies, B.N., Ferry, C.B.: The effect of neuronal rest on the output of sympathetic transmitter from the spleen. J. Physiol. (Lond.) 159, 365–380 (1961)
Brown, G.L., Davies, B.N., Gillespie, J.S.: The release of chemical transmitter from the sympathetic nerves of the intestine of the cat. J. Physiol. (Lond.) 143, 41–54 (1958)
Brown, G.L., Gillespie, J.S.: Output of sympathin from the spleen. Nature (Lond.) 178, 980 (1956)
Brown, G.L., Gillespie, J.S.: The output of sympathetic transmitter from the spleen of the cat. J. Physiol. (Lond.) 138, 81–102 (1957)
Brücke, F.T.: Über dic Wirkung von Acetylcholin auf dic Pilomotoren. Klin. Wschr. 14, 7–9 (1935)
Bryant, B.J., McCulloch, M.W., Rand, M.J., Story, D.F.: Release of 3H-(−)-noradrenaline from guinea-pig hypothalamic slices: effects of adrenoceptor agonists and antagonists. Brit. J. Pharmacol. 53, 454P (1975)
Eülbring, E., Burn, J.H., Elio, F.J. de: The secretion of adrenaline from the perfused suprarenal gland. J. Physiol. (Lond.) 107, 222–232 (1948)
Burn, J.H., Gibbons, W.R.: The effect of phenoxybenzamine and of tolazoline on the response to sympathetic stimulation. Brit. J. Pharmacol. 22, 527–539 (1964a)
Burn, J.H., Gibbons, W.R.: The part played by calcium in determining the response to stimulation of sympathetic postganglionic fibres. Brit. J. Pharmacol. 22, 540–548 (1964b)
Burn, J.H., Ng, K.K.F.: The action of pempidine and antiadrenaline substances at the sympathetic postganglionic termination. Brit. J. Pharmacol. 24, 675–688 (1965)
Burn, J.H., Rand, M.J.: Sympathetic postganglionic mechanism. Nature (Lond.) 184, 163–165 (1959)
Burnstock, G., Holman, M.E., Kuriyama, H.: Facilitation of transmission from autonomic nerve to smooth muscle of guinea-pig vas deferens. J. Physiol. (Lond.) 172, 31–49 (1964)
Cabrera, R., Torrance, R.W., Viveros, H.: The action of acetyl choline and other drugs upon the terminal parts of the postganglionic sympathetic fibre. Brit. J. Pharmacol. 27, 51–63 (1966)
Cairnie, A.B., Kosterlitz, H.W., Taylor, D.W.: Effect of morphine on some sympathetically innervated effectors. Brit. J. Pharmacol. 17, 539–551 (1961)
Cardenas, H.L., Ross, D.H.: Morphine induced calcium depletion in discrete regions of rat brain. J. Neurochem. 24, 487–493 (1975)
Carlsson, A.: Dopaminergic autoreceptors. In: Almgren, O., Carlsson, A., Engel, J. (eds.), Chemical Tools in Catecholamine Research, Vol. 2, pp. 219–225. Amsterdam-Oxford: North-Holland 1975
Carlsson, A., Lindqvist, M.: Central and peripheral monoaminergic membrane-pump blockade by some addictive analgesics and antihistamines. J. Pharm. Pharmacol. 21, 460–464 (1969)
Carmichael, F.J., Israel, Y.: In vitro inhibitory effects of narcotic analgesics and other psychotropic drugs on the active uptake of norepinephrine in mouse brain tissue. J. Pharmacol. exp. Ther. 186, 253–260 (1973)
Celsen, B., Kuschinsky, K.: Effects of morphine on kinetics of 14C-dopamine in rat striatal slices. Naunyn-Schmiedeberg's Arch. Pharmacol. 284, 159–165 (1974)
Cervoni, P., Reit, E.: Interaction of angiotensin with exogenous and neurally released norepinephrine on the cat nictitating membrane in vitro. J. Pharmacol. exp. Ther. 193, 1–8 (1975)
Chalmers, J.P.: Brain amines and models of experimental hypertension. Circulat. Res. 36, 469–480 (1975)
Chanh, P.H., Junstad, M., Wennmalm, Å.: Augmented noradrenaline release following nerve stimulation after inhibition of prostaglandin synthesis with indomethacin. Acta physiol. scand. 86, 563–567 (1972)
Chevillard, C., Alexandre, J.: Action, in vitro et in vivo, de l'angiotensine II sur le captage cardiaque de la noradrenaline. Experientia (Basel) 26, 1334–1336 (1970)
Chevillard, C., Alexandre, J.M.: In vitro effects on cardiac norepinephrine of angiotensin II and of two indirectly acting sympathomimetic amines (amphetamine and tyramine). A study of their combinations. Europ. J. Pharmacol. 19, 223–230 (1972)
Chevillard, C., Duchène, N., Alexandre, J.M.: Selective release of newly synthesized cardiac norepinephrine induced by angiotensin II. Europ. J. Pharmacol. 15, 8–14 (1971)
Chevillard, C., Duchene, N., Alexandre, J.M.: How does angiotensin II increase cardiac dopamine-β-hydroxylation? J. Pharm. Pharmacol. 27, 193–196 (1975)
Chiba, T., Doba, N.: Catecholaminergic axo-axonic synapses in the nucleus of the tractus solitarius (pars commissuralis) of the cat: Possible relation to presynaptic regulation of baroreceptor reflexes. Brain Res. 102, 255–265 (1976)
Chubb, I.W., Potter, W.P. de, Schaepdryver, A.F. de: Tyramine does not release noradrenaline from splenic nerve by exocytosis. Naunyn-Schmiedeberg's Arch. Pharmacol. 274, 281–286 (1972)
Cicero, T.J., Meyer, E.R., Smithloff, B.R.: Alpha adrenergic blocking agents: Antinociceptive activity and enhancement of morphine-induced analgesia. J. Pharmacol. exp. Ther. 189, 72–82 (1974)
Cicero, T.J., Wilcox, C.E., Smithloff, B.R., Meyer, E.R., Sharpe, L.G.: Effects of morphine, in vitro and in vivo, on tyrosine hydroxylase activity in rat brain. Biochem. Pharmacol. 22, 3237–3246 (1973)
Ciofalo, F.R.: Effects of some narcotics and antagonists on synaptosomal 3H-norepinephrine uptake. Life Sci. 11, I, 573–580 (1972)
Ciofalo, F.R.: Prostaglandins and synaptosomal transport of 3H-norepinephrine and 3H-5-hydroxytryptamine. Res. Commun, chem. Pathol. Pharmacol. 5, 551–554 (1973)
Ciofalo, F.R.: Methadone inhibition of 3H-5-hydroxytryptamine uptake by synaptosomes. J. Pharmacol. exp. Ther. 189, 83–89 (1974)
Clarenbach, P., Raffel, G., Meyer, D., Hertting, G.: Inhibition of uptake of catecholamines into rat brain synaptosomes by inhibitors of prostaglandin synthesis. Naunyn-Schmiedeberg's Arch. Pharmacol. 285, R9 (1974)
Clarenbach, P., Raffel, G., Meyer, D.K., Hertting, G.: Inhibition by indomethacin and niflumic acid of catecholamine-uptake into rat hypothalamic and striatal synaptosomes. Arch. int. Pharmacodyn. 219, 79–86 (1976)
Clark, K.E., Ryan, M.J., Brody, M.J.: Effects of prostaglandins E1 and F2α on uterine hemodynamics and motility. Advanc. Biosci. 9, 779–782 (1973)
Clouet, D.H., Johnson, J.C., Ratner, M., Williams, N., Gold, G.J.: The effect of morphine on rat brain catecholamines: Turnover in vivo and uptake in isolated synaptosomes. In: Usdin, E., Snyder, S.H. (eds.), Frontiers in Catecholamine Research, pp. 1039–1042. New York: Pergamon Press 1973
Clouet, D.H., Williams, N.: The effect of narcotic analgesic drugs on the uptake and release of neurotransmitters in isolated synaptosomes. J. Pharmacol. exp. Ther. 188, 419–428 (1974)
Collier, H.O.J.: Supersensitivity and dependence. Nature (Lond.) 220, 228–231 (1968)
Collier, H.O.J., McDonald-Gibson, W.J., Saeed, S.A.: Morphine and apomorphine stimulate prostaglandin production by rabbit brain homogenate. Brit. J. Pharmacol. 52, 116P (1974)
Coon, J.M., Rothman, S.: The nature of the pilomotor response to acetyl choline; some observations on the pharmacodynamics of the skin. J. Pharmacol. exp. Ther. 68, 301–311 (1940)
Cox, B.M., Weinstock, M.: The effect of analgesic drugs on the release of acetylcholine from electrically stimulated guinea-pig ileum. Brit. J. Pharmacol. 27, 81–92 (1966)
Cripps, H., Dearnaley, D.P.: Vascular responses and noradrenaline overflows in the isolated blood-perfused cat spleen: Some effects of cocaine, normetanephrine and α-blocking agents. J. Physiol. (Lond.) 227, 647–664 (1972)
Cubeddu, L.X., Barnes, E.M., Langer, S.Z., Weiner, N.: Release of norepinephrine and dopamine-β-hydroxylase by nerve stimulation. I. Role of neuronal and extraneuronal uptake and of alpha presynaptic receptors. J. Pharmacol. exp. Ther. 190, 431–450 (1974a)
Cubeddu, L.X., Barnes, E., Weiner, N.: Release of norepinephrine and dopamine-β-hydroxylase by nerve stimulation. II. Effects of papaverine. J. Pharmacol. exp. Ther. 191, 444–457 (1974b)
Cubeddu, L.X., Barnes, E., Weiner, N.: Release of norepinephrine and dopamine-β-hydroxylase by nerve Stimulation. IV. An evaluation of a role for cyclic adenosine monophosphate. J. Pharmacol. exp. Ther. 193, 105–127 (1975)
Cubeddu, L.X., Langer, S.Z., Weiner, N.: The relationships between alpha receptor block, inhibition of norepinephrine uptake and the release and metabolism of 3H-norepinephrine. J. Pharmacol. exp. Ther. 188, 368–385 (1974c)
Cubeddu, L.X., Weiner, N.: Nerve stimulation-mediated overflow of norepinephrine and dopamine-β-hydroxylase. III. Effects of norepinephrine depletion on the alpha presynaptic regulation of release. J. Pharmacol. exp. Ther. 192, 1–14 (1975a)
Cubeddu, L.X., Weiner, N.: Release of norepinephrine and dopamine-β-hydroxylase by nerve stimulation. V. Enhanced release associated with a granular effect of a benzoquinolizine derivative with reserpine-like properties. J. Pharmacol. exp. Ther. 193, 757–774 (1975b)
Dahlöf, C., Åblad, B., Borg, K.O., Ek, L., Waldeck, B.: Prejunctional inhibition of adrenergic nervous vasomotor control due to β receptor blockade. In: Almgren, O., Carlsson, A., Engel, J. (eds.), Chemical Tools in Catecholamine Research, Vol. 2, pp. 201–210. Amsterdam-Oxford: North-Holland 1975
Dalemans, P., Janssens, W., Verbeuren, T., Vanhoutte, P.M.: Effects of naturally occurring catechol-amines on adrenergic neuro-effector interaction in isolated cutaneous veins. Arch. int. Pharmacodyn. 220, 333–334 (1976)
Davey, M.J., Hayden, M.L., Scholfield, P.C.: The effects of bretylium on C fibre excitation and noradrenaline release by acetylcholine and electrical stimulation. Brit. J. Pharmacol. 34, 377–387 (1968)
Davies, B.N., Horton, E.W., Withrington, P.G.: The occurrence of prostaglandin E2 in splenic venous blood of the dog following splenic nerve stimulation. Brit. J. Pharmacol. 32, 127–135 (1968)
Davies, B.N., Withrington, P.G.: Actions of prostaglandins A1 A2, E1, E2, F1α, and F2α on splenic vascular and capsular smooth muscle and their interactions with sympathetic nerve stimulation, catecholamines and angiotensin. In: Mantegazza, P., Horton, E.W. (eds.), Prostaglandins, Peptides and Amines, pp. 53–56. London-New York: Academic Press 1969
Davila, D., Khairallah, P.A.: Effect of ions on inhibition of norepinephrine uptake by angiotensin. Arch. int. Pharmacodyn. 185, 357–364 (1970)
Davila, D., Khairallah, P.A.: Angiotensin and biosynthesis of norepinephrine. Arch. int. Pharmacodyn. 193, 307–314 (1971)
Davis, H.A., Horton, E.W.: Output of prostaglandins from the rabbit kidney, its increase on renal nerve stimulation and its inhibition by indomethacin. Brit. J. Pharmacol. 46, 658–675 (1972)
Dawes, P.M., Faulkner, D.C.: The effect of propranolol on vascular responses to sympathetic nerve stimulation. Brit. J. Pharmacol. 53, 517–524 (1975)
Dawes, P.M., Vizi, E.S.: Acetylcholine release from the rabbit isolated superior cervical ganglion preparation. Brit. J. Pharmacol. 48, 225–232 (1973)
Day, M.D., Moore, A.F.: Interaction of angiotensin II with noradrenaline and other spasmogens on rabbit isolated aortic strips. Arch. int. Pharmacodyn. 219, 29–44 (1976)
Day, M.D., Owen, D.A.A., Warren, P.R.: An adrenergic neuron blocking action of propranolol in isolated tissues. J. Pharm. Pharmacol. 20, 130–134S (1968)
Deck, R., Oberdorf, A., Kroneberg, G.: Dic Wirkung von 2-(2,6-Dichlorphenylamino)-2-imidazolin-Hydrochlorid (Clonidin) auf dic Kontraktion und dic Acetylcholin-Freisetzung am isolierten, koaxial elektrisch gereizten Meerschweinchenileum. Arzneimittel-Forsch. 21, 1580–1584 (1971)
Dengler, H.J., Titus, E.O.: Dic Aufnahme von H3-Noradrenalin in Gewebeschnitte und deren Beeinflussung durch Pharmaka. Naunyn-Schmiedeberg's Arch. exp. Path. Pharmakol. 241, 523 (1961)
Douglas, W.W., Kanno, T., Sampson, S.R.: Effects of acetylcholine and other medullary secretagogues and antagonists on the membrane potential of adrenal chromaffin cells: An analysis employing techniques of tissue culture. J. Physiol. (Lond.) 188, 107–120 (1967)
Drew, G.M.: Effects of α-adrenoceptor agonists and antagonists on pre-and postsynaptically located α-adrenoceptors. Europ. J. Pharmacol. 36, 313–320 (1976)
Dubey, M.P., Muscholl, E., Pfeiffer, A.: Muscarinic inhibition of potassium-induced noradrenaline release and its dependence on the calcium concentration. Naunyn-Schmiedeberg's Arch. Pharmacol. 291, 1–15 (1975)
Dubocovich, M., Langer, S.Z.: Effects of flow-stop on the metabolism of noradrenaline released by nerve stimulation in the perfused spleen. Naunyn-Schmiedeberg's Arch. Pharmacol. 278, 179–194 (1973)
Dubocovich, M.L., Langer, S.Z.: Negative feed-back regulation of noradrenaline release by nerve stimulation in the perfused cat's spleen: Differences in potency of phenoxybenzamine in blocking the pre-and post-synaptic adrenergic receptors. J. Physiol. (Lond.) 237, 505–519 (1974)
Dubocovich, M.L., Langer, S.Z.: Evidence against a physiological role of prostaglandins in the regulation of noradrenaline release in the cat spleen. J. Physiol. (Lond.) 251, 737–762 (1975)
Dun, N., Nishi, S.: Effects of dopamine on the superior cervical ganglion of the rabbit. J. Physiol. (Lond.) 239, 155–164 (1974)
Eccles, J.C.: The Physiology of Synapses. Berlin-Göttingen-Heidelberg: Springer 1964
Ehrenpreis, S., Greenberg, J., Belman, S.: Prostaglandins reverse inhibition of electrically-induced contractions of guinea pig ileum by morphine, indomethacin and acetylsalicylic acid. Nature (Lond.) 245, 280–282 (1973)
Eisenfeld, A.J., Axelrod, J., Krakoff, L.: Inhibition of the extraneuronal accumulation and metabolism of norepinephrine by adrenergic blocking agents. J. Pharmacol. exp. Ther. 156, 107–113 (1967)
Eliash, S., Weinstock, M.: Role of adrenergic neurone blockade in the hypotensive action of propranolol. Brit. J. Pharmacol. 43, 287–294 (1971)
Elie, R., Panisset, J.C.: Effect of angiotensin and atropine on the spontaneous release of acetylcholine from cat cerebral cortex. Brain Res. 17, 297–305 (1970)
Endoh, M., Tamura, K., Hashimoto, K.: Negative and positive inotropic responses of the blood-perfused canine papillary muscle to acetylcholine. J. Pharmacol. exp. Ther. 175, 377–387 (1970)
Enero, M.A., Langer, S.Z.: Influence of reserpine-induced depletion of noradrenaline on the negative feed-back mechanism for transmitter release during nerve stimulation. Brit. J. Pharmacol. 49, 214–225 (1973)
Enero, M.A., Langer, S.Z.: Inhibition by dopamine of 3H-noradrenaline release elicited by nerve stimulation in the isolated cat's nictitating membrane. Naunyn-Schmiedeberg's Arch. Pharmacol. 289, 179–203 (1975)
Enero, M.A., Langer, S.Z., Rothlin, R.P., Stefano, F.J.E.: Role of the α-adrenoceptor in regulating noradrenaline overflow by nerve stimulation. Brit. J. Pharmacol. 44, 672–688 (1972)
Euler, U.S. von: Synthesis, uptake and storage of catecholamines in adrenergic nerves, the effect of drugs. In: Blaschko, H., Muscholl, E. (eds.), Catecholamines. Handbuch der experimentellen Pharmakologie, Vol. 33, pp. 186–230. Berlin-Heidelberg-New York: Springer 1972
Euler, U.S. von, Hedqvist, P.: Evidence for an α-and β 2-receptor mediated inhibition of the twitch response in the guinea pig vas deferens by noradrenaline. Acta physiol. scand. 93, 572–573 (1975)
Euler, U.S. von, Lishajko, F.: Noradrenaline release from isolated nerve granules. Acta physiol. scand. 51, 193–203 (1961)
Farah, M.B., Langer, S.Z.: Protection by phentolamine against the effects of phenoxybenzamine on transmitter release elicited by nerve stimulation in the perfused cat heart. Brit. J. Pharmacol. 52, 549–557 (1974)
Farnebo, L.O., Hamberger, B.: Effects of desipramine, phentolamine and phenoxybenzamine on the release of noradrenaline from isolated tissues. J. Pharm. Pharmacol. 22, 855–857 (1970)
Farnebo, L.O., Hamberger, B.: Drug-induced changes in the release of (3H)-noradrenaline from field stimulated rat iris. Brit. J. Pharmacol. 43, 97–106 (1971a)
Farnebo, L.O., Hamberger, B.: Drug-induced changes in the release of 3H-monoamines from field stimulated rat brain slices. Acta physiol. scand., Suppl. 371, 35–44 (1971b)
Farnebo, L.O., Hamberger, B.: Chronic decentralization prevents α-receptor mediated regulation of noradrenaline release in the field stimulated rat iris. Brain Res. 62, 477–482 (1973a)
Farnebo, L.O., Hamberger, B.: Catecholamine release and receptors in brain slices. In: Usdin, E., Snyder, S.H. (eds.), Frontiers in Catecholamine Research, pp. 589–593. New York: Pergamon Press 1973b
Farnebo, L.O., Hamberger, B.: Regulation of (3H)5-hydroxytryptamine release from rat brain slices. J. Pharm. Pharmacol. 26, 642–644 (1974a)
Farnebo, L.O., Hamberger, B.: Influence of α-and β-adrenoceptors on the release of noradrenaline from field stimulated atria and cerebral cortex slices. J. Pharm. Pharmacol. 26, 644–646 (1974b)
Farnebo, L.O., Malmfors, T.: 3H-noradrenaline release and mechanical response in the field stimulated mouse vas deferens. Acta physiol. scand., Suppl. 371, 1–18 (1971)
Feniuk, W., Large, B.J.: The effects of prostaglandins E1 E2 and F2α on vagal bradycardia in the anaesthetized mouse. Brit. J. Pharmacol. 55, 47–49 (1975)
Ferry, C.B.: The sympathomimetic effect of acetylcholine on the spleen of the cat. J. Physiol. (Lond.) 167, 487–504 (1963)
Ferry, C.B.: Cholinergic link hypothesis in adrenergic neuroeffector transmission. Physiol. Rev. 46, 420–456 (1966)
Fischer, J.E., Weise, V.K., Kopin, I.J.: Interactions of bretylium and acetylcholine at sympathetic nerve endings. J. Pharmacol. exp. Ther. 153, 523–529 (1966)
Flower, R.J.: Drugs which inhibit prostaglandin biosynthesis. Pharmacol. Rev. 26, 33–67 (1974)
Foo, J.W., Jowett, A., Stafford, A.: The effects of some β-adrenoreceptor blocking drugs on the uptake and release of noradrenaline by the heart. Brit. J. Pharmacol. 34, 141–147 (1968)
Fozard, J.R., Muscholl, E.: Effects of several muscarinic agonists on cardiac performance and the release of noradrenaline from sympathetic nerves of the perfused rabbit heart. Brit. J. Pharmacol. 45, 616–629 (1972)
Fozard, J.R., Muscholl, E.: Atropine-resistant effects of the muscarinic agonists McN-A-343 and AHR 602 on cardiac performance and the release of noradrenaline from sympathetic nerves of the perfused rabbit heart. Brit. J. Pharmacol. 50, 531–541 (1974)
Fozard, J.R., Mwaluko, G.M.P.: Mechanism of the indirect sympathomimetic effect of 5-hydroxytryptamine on the isolated heart of the rabbit. Brit. J. Pharmacol. 57, 115–125 (1976)
Frame, M.H., Hedqvist, P.: Evidence for prostaglandin mediated prejunctional control of renal sympathetic transmitter release and vascular tone. Brit. J. Pharmacol. 54, 189–196 (1975)
Fredholm, B., Hedqvist, P.: Increased release of noradrenaline from stimulated guinea pig vas deferens after indomethacin treatment. Acta physiol. scand. 87, 570–572 (1973a)
Fredholm, B.B., Hedqvist, P.: Role of pre-and postjunctional inhibition by prostaglandin E2 of lipolysis induced by sympathetic nerve stimulation in dog subcutaneous adipose tissue in situ. Brit. J. Pharmacol. 47, 711–718 (1973b)
Fredholm, B.B., Hedqvist, P.: Indomethacin and the role of prostaglandins in adipose tissue. Biochem. Pharmacol. 24, 61–66 (1975a)
Fredholm, B.B., Hedqvist, P.: Indomethacin-induced increase in noradrenaline turnover in some rat organs. Brit. J. Pharmacol. 54, 295–300 (1975b)
Fredholm, B.B., Rosell, S.: Fate of 3H-noradrenaline in canine subcutaneous adipose tissue. Acta physiol. scand. 80, 404–411 (1970)
Fredholm, B.B., Rosell, S., Strandberg, K.: Release of prostaglandin-like material from canine subcutaneous adipose tissue by nerve stimulation. Acta physiol. scand. 79, 18–19A (1970)
Fuder, H., Muscholl, E.: The effect of methacholine on noradrenaline release from the rabbit heart perfused with indometacin. Naunyn-Schmiedeberg's Arch. Pharmacol. 285, 127–132 (1974)
Furchgott, R.F.: The receptors for epinephrine and norepinephrine (adrenergic receptors). Pharmacol. Rev. 11, 429–441 (1959)
Furchgott, R.F.: The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blaschko, H., Muscholl, E. (eds.), Catecholamines. Handbuch der experimentellen Pharmakologie, Vol. 33, pp. 283–335. Berlin-Heidelberg-New York: Springer 1972
Furchgott, R.F., Steinsland, O.S., Wakade, T.D.: Studies on prejunctional muscarinic and nicotinic receptors. In: Almgren, O., Carlsson, A., Engel, J. (eds.), Chemical Tools in Catecholamine Research, Vol. 2, pp. 167–174. Amsterdam-Oxford: North-Holland 1975
Gagnon, D.J., Sirois, P., Boucher, P.J.: Stimulation by angiotensia II of the release of vasopressin from incubated rat neurohypophyses-possible involvement of cyclic AMP. Clin. exp. Pharmacol. Physiol. 2, 305–313 (1975)
Garcia, A.G., Kirpekar, S.M.: Release of noradrenaline from the cat spleen by sodium deprivation. Brit. J. Pharmacol. 47, 729–747 (1973)
Garcia, A.G., Kirpekar, S.M.: On the mechanism of release of norepinephrine from cat spleen slices by sodium deprivation and calcium pretreatment. J. Pharmacol. exp. Ther. 192, 343–350 (1975)
Geffen, L.B.: The effect of desmethylimipramine upon the overflow of sympathetic transmitter from the cat's spleen. J. Physiol. (Lond.) 181, 69–70P (1965)
George, A.J.: The effect of prostaglandin E1 and E2 on drug-induced release of (3H)-noradrenaline from rat mesenteric arteries. Brit. J. Pharmacol. 55, 243P (1975)
Gilbert, J.C., Wyllie, M.G., Davison, D.V.: Nerve terminal ATPase as possible trigger for neuro-transmitter release. Nature (Lond.) 255, 237–238 (1975)
Gillespie, J.S., Kirpekar, S.M.: The uptake and release of radioactive noradrenaline by the splenic nerves of cats. J. Physiol. (Lond.) 187, 51–68 (1966)
Gilmore, N., Vane, J.R., Wyllie, J.H.: Prostaglandins released by the spleen. Nature (Lond.) 218, 1135–1140 (1968)
Giorguieff, M.F., Le Floc'h, M.L., Westfall, T.C., Glowinski, J., Besson, M.J.: Nicotinic effect of acetylcholine on the release of newly synthesized (3H)dopamine in rat striatal slices and cat caudate nucleus. Brain Res. 106, 117–131 (1976)
Göthert, M.: Effects of halothane on the sympathetic nerve terminals of the rabbit heart. Differences in membrane actions of halothane and tetracaine. Naunyn-Schmiedeberg's Arch. Pharmacol. 286, 125–143 (1974)
Göthert, M., Kennerknecht, E., Thielecke, G.: Inhibition of receptor-mediated noradrenaline release from the sympathetic nerves of the isolated rabbit heart by anaesthetics and alcohols in proportion to their hydrophobic property. Naunyn-Schmiedeberg's Arch. Pharmacol. 292, 145–152 (1976)
Goldberg, L.I.: Cardiovascular and renal actions of dopamine: Potential clinical applications. Pharmacol. Rev. 24, 1–29 (1972)
Goldberg, L.I.: The dopamine vascular receptor. Biochem. Pharmacol. 24, 651–653 (1975)
Goldberg, L.I., Sonneville, P.F., McNay, J.L.: An investigation of the structural requirements for dopamine-like renal vasodilation: Phenylethylamines and apomorphine. J. Pharmacol. exp. Ther. 163, 188–197 (1968)
Goldberg, L.I., Tjandramaga, T.B., Anton, A.H., Toda, N.: New investigations of the cardiovascular actions of dopamine. In: Usdin, E., Snyder, S.H. (eds.), Frontiers in Catecholamine Research, pp. 513–521. New York: Pergamon Press 1973
Gomer, S.K., Zimmerman, B.G.: Effect of angiotensin II on uptake and release of dl-3H-metaraminol. Proc. Soc. exp. Biol. (N.Y.) 142, 787–792 (1973)
Goodman, F.R.: Effects of nicotine on distribution and release of 14C-norepinephrine and 14C dopamine in rat brain striatum and hypothalamus slices. Neuropharmacol. 13, 1025–1032 (1974)
Govier, W.C.: Myocardial alpha adrenergic receptors and their role in the production of a positive inotropic effect by sympathomimetic agents. J. Pharmacol. exp. Ther. 159, 82–90 (1968)
Grabowska, M., Andén, N.E.: Noradrenaline synthesis and utilization: Control by nerve impulse flow under normal conditions and after treatment with alpha-adrenoreceptor blocking agents. Naunyn-Schmiedeberg's Arch. Pharmacol. 292, 53–58 (1976)
Graefe, K.H.: Methodology of catecholamine transport studies: Definition of terms. In: Paton, D.M. (ed.), The Mechanism of Neuronal and Extraneuronal Transport of Catecholamines, pp. 7–35. New York: Raven Press 1976
Graefe, K.H., Stefano, F.J.E., Langer, S.Z.: Preferential metabolism of (−)-3H-norepinephrine through the deaminated glycol in the rat vas deferens. Biochem. Pharmacol. 22, 1147–1160 (1973)
Greenberg, R.: The effects of indomethacin and eicosa-5,8,11,14-tetraynoic acid on the response of the rabbit portal vein to electrical stimulation. Brit. J. Pharmacol. 52, 61–68 (1974)
Greenberg, S., Howard, L., Wilson, W.R.: Comparative effects of prostaglandins A2 and B2 on vascular and airway resistances and adrenergic neurotransmission. Canad. J. Physiol. Pharmacol. 52, 699–705 (1974)
Greengard, P., Kebabian, J.W.: Role of cyclic AMP in synaptic transmission in the mammalian peripheral nervous system. Fed. Proc. 33, 1059–1067 (1974)
Guidotti, A., Costa, E.: A role for nicotinic receptors in the regulation of the adenylate cyclase of adrenal medulla. J. Pharmacol. exp. Ther. 189, 665–675 (1974)
Gustafsson, L., Hedqvist, P., Lagercrantz, H.: Potentiation by prostaglandins E1, E2, and F2α of the contraction response to transmural stimulation in the bovine iris sphincter muscle. Acta physiol. scand. 95, 26–33 (1975)
Gutman, Y., Boonyaviroj, P.: Suppression by noradrenaline of catecholamine secretion from adrenal medulla. Europ. J. Pharmacol. 28, 384–386 (1974)
Gutman, Y., Boonyaviroj, P.: Regulation of catecholamine release from adrenal medulla in vitro by α and β receptors and by prostaglandins. In: Abstr. 6th Int. Congr. Pharmacol., Helsinki, 1975, p. 423
Hadházy, P., Illés, P., Knoll, J.: The effects of PGE1 on responses to cardiac vagus nerve stimulation and acetylcholine release. Europ. J. Pharmacol. 23, 251–255 (1973)
Hadházy, P., Vizi, E.S., Magyar, K., Knoll, J.: Inhibition of adrenergic neurotransmission by prostaglandin E1 (PGE1 in the rabbit ear artery. Neuropharmacol. 15, 245–250 (1976)
Haefely, W.: Electrophysiology of the adrenergic neuron. In: Blaschko, H., Muscholl, E. (eds.), Catecholamines. Handbuch der experimentellen Pharmakologie, Vol. 33, pp. 661–725. Berlin-Heidelberg-New York: Springer 1972
Häggendal, J.: On release of transmitter from adrenergic nerve terminals at nerve activity. Acta physiol. scand., Suppl. 330, 29 (1969)
Häggendal, J.: Some further aspects on the release of the adrenergic transmitter. In: Schümann, H.J., Kroneberg, G. (eds.), New Aspects of Storage and Release Mechanisms of Catecholamines, pp. 100–109. Berlin-Heidelberg-New York: Springer 1970
Häggendal, J., Johansson, B., Jonason, J., Ljung, B.: Effects of phenoxybenzamine on transmitter release and effector response in the isolated portal vein. J. Pharm. Pharmacol. 24, 161–164 (1972)
Haeusler, G.: Clonidine-induced inhibition of sympathetic nerve activity: No indication for a central presynaptic or an indirect sympathomimetic mode of action. Naunyn-Schmiedeberg's Arch. Pharmacol. 286, 97–111 (1974)
Haeusler, G.: The importance of the presynaptic β-adrenergic regulation of noradrenaline release from vascular nerves in vivo. Naunyn-Schmiedeberg's Arch. Pharmacol. 287, R19 (1975a)
Haeusler, G.: Cardiovascular regulation by central adrenergic mechanisms and its alteration by hypotensive drugs. Circulat. Res. 36–37, I–223–232 (1975b)
Haeusler, G., Haefely, W., Huerlimann, A.: On the mechanism of the adrenergic nerve blocking action of bretylium. Naunyn-Schmiedebergs Arch. Pharmakol. 265, 260–277 (1969a)
Haeusler, G., Thoenen, H., Haefely, W., Huerlimann, A.: Electrical events in cardiac adrenergic nerves and noradrenaline release from the heart induced by acetylcholine and KCl. Naunyn-Schmiedebergs Arch. Pharmakol. exp. Path. 261, 389–411 (1968)
Haeusler, G., Thoenen, H., Haefely, W., Huerlimann, A.: Elektrosekretorische Koppelung bei der Noradrenalinfreisetzung aus adrenergen Nervenfasern durch nicotinartig wirkende Substanzen. Naunyn-Schmiedebergs Arch. Pharmakol. exp. Path. 263, 217–218 (1969b)
Hahn, R.A., Patil, P.N.: Further observations on the interaction of prostaglandin F2α with cholinergic mechanisms in canine salivary glands. Europ. J. Pharmacol. 25, 279–286 (1974)
Hall, G.H., Turner, D.M.: Effects of nicotine on the release of 3H-noradrenaline from the hypothalamus. Biochem. Pharmacol. 21, 1829–1838 (1972)
Hazra, J.: Evidence against prostaglandin E having a physiological role in acetylcholine liberation from Auerbach's plexus of guinea-pig ileum. Experientia (Basel) 31, 565–566 (1975)
Hedqvist, P.: Modulating effect of prostaglandin E2 on noradrenaline release from the isolated cat spleen. Acta physiol. scand. 75, 511–512 (1969a)
Hedqvist, P.: Antagonism between prostaglandin E2 and phenoxybenzamine on noradrenaline release from the cat spleen. Acta physiol. scand. 76, 383–384 (1969b)
Hedqvist, P.: Control by prostaglandin E2 of sympathetic neurotransmission in the spleen. Life Sci. 9, I, 269–278 (1970a)
Hedqvist, P.: Antagonism by calcium of the inhibitory action of prostaglandin E2 on sympathetic neurotransmission in the cat spleen. Acta physiol. scand. 80, 269–275 (1970b)
Hedqvist, P.: Studies on the effect of prostaglandins E1 and E2 on the sympathetic neuromuscular transmission in some animal tissues. Acta physiol. scand., Suppl. 345 (1970c)
Hedqvist, P.: Prostaglandin induced inhibition of neurotransmission in the isolated guinea pig seminal vesicle. Acta physiol. scand. 84, 506–511 (1972a)
Hedqvist, P.: Prostaglandin-induced inhibition of vascular tone and reactivity in the cat's hindleg in vivo. Europ. J. Pharmacol. 17, 157–162 (1972b)
Hedqvist, P.: Prostaglandin mediated control of sympathetic neuroeffector transmission. Advanc. Biosci. 9, 461–473 (1973a)
Hedqvist, P.: Autonomic neurotransmission. In: Ramwell, P.W. (ed.), The Prostaglandins, Vol. 1, pp. 101–131. New York-London: Plenum Press 1973b
Hedqvist, P.: Prostaglandin as a tool for local control of transmitter release from sympathetic nerves. Brain Res. 62, 483–488 (1973c)
Hedqvist, P.: Aspects on prostaglandin and α-receptor mediated control of transmitter release from adrenergic nerves. In: Usdin, E., Snyder, S.H. (eds.), Frontiers in Catecholamine Research, pp. 583–587. New York: Pergamon Press 1973d
Hedqvist, P.: Dissociation of prostaglandin and α-receptor mediated control of adrenergic transmitter release. Acta physiol. scand. 87, 42–43A (1973e)
Hedqvist, P.: Prostaglandin action on noradrenaline release and mechanical responses in the stimulated guinea pig vas deferens. Acta physiol. scand. 90, 86–93 (1974a)
Hedqvist, P.: Interaction between prostaglandins and calcium ions on noradrenaline release from the stimulated guinea pig vas deferens. Acta physiol. scand. 90, 153–157 (1974b)
Hedqvist, P.: Role of the α-receptor in the control of noradrenaline release from sympathetic nerves. Acta physiol. scand. 90, 158–165 (1974c)
Hedqvist, P.: Restriction of transmitter release from adrenergic nerves mediated by prostaglandins and α-adrenoreceptors. Pol. J. Pharmacol. Pharm. 26, 119–125 (1974d)
Hedqvist, P.: Effect of prostaglandins and prostaglandin synthesis inhibitors on norepinephrine release from vascular tissue. In: Robinson, H.J., Vane, J.R. (eds.), Prostaglandin Synthetase Inhibitors, pp. 303–309. New York: Raven Press 1974e
Hedqvist, P., Brundin, J.: Inhibition by prostaglandin E1 of noradrenaline release and of effector response to nerve stimulation in the cat spleen. Life Sci. 8, I, 389–395 (1969)
Hedqvist, P., Euler, U.S. von: Prostaglandin-induced neurotransmission failure in the field-stimulated, isolated vas deferens. Neuropharmacol. 11, 177–187 (1972)
Hedqvist, P., Moawad, A.: Presynaptic α-and β-adrenoceptor mediated control of noradrenaline release in human oviduct. Acta physiol. scand. 95, 494–496 (1975)
Hedqvist, P., Persson, N.Å.: Prostaglandin action on adrenergic and cholinergic responses in the rabbit and guinea pig intestine. In: Almgren, O., Carlsson, A., Engel, J. (eds.), Chemical Tools in Catecholamine Research, Vol. 2, pp. 211–218. Amsterdam-Oxford: North-Holland 1975
Hedqvist, P., Stjärne, L., Wennmalm, Å.: Inhibition by prostaglandin E2 of sympathetic neurotransmission in the rabbit heart. Acta physiol. scand. 79, 139–141 (1970)
Hedqvist, P., Stjärne, L., Wennmalm, Å.: Facilitation of sympathetic neurotransmission in the cat spleen after inhibition of prostaglandin synthesis. Acta physiol. scand. 83, 430–432 (1971)
Hedqvist, P., Wennmalm, Å.: Comparison of the effects of prostaglandins E1 E2 and F2α on the sympathetically stimulated rabbit heart. Acta physiol. scand. 83, 156–162 (1971)
Heikkila, R.E., Orlansky, H., Cohen, G.: Studies on the distinction between uptake inhibition and release of (3H)dopamine in rat brain tissue slices. Biochem. Pharmacol. 24, 847–852 (1975)
Heise, A., Kroneberg, G.: Periphere und zentrale Kreislaufwirkung des α-Sympathicomimeticums 2-(2,6-Xylidino)-5,6-dihydro-4H-1,3-thiazinhydrochlorid (BAY 1470). Naunyn-Schmiedebergs Arch. Pharmakol. 266, 350 (1970)
Heise, A., Kroneberg, G., Schlossmann, K.: α-sympathicomimetische Eigenschaften als Ursache der blutdrucksteigernden und blutdrucksenkenden Wirkung von BAY 1470 (2-(2,6-Xylidino)-5,6-dihydro-4H-1,3-thiazinhydrochlorid). Naunyn-Schmiedebergs Arch. Pharmakol. 268, 348–360 (1971)
Henderson, G., Hughes, J.: Modulation of frequency-dependent noradrenaline release by calcium, angiotensin and morphine. Brit. J. Pharmacol. 52, 455–456P (1974)
Henderson, G., Hughes, J., Kosterlitz, H.W.: A new example of a morphine-sensitive neuro-effector junction: adrenergic transmission in the mouse vas deferens. Brit. J. Pharmacol. 46, 764–766 (1972a)
Henderson, G., Hughes, J., Kosterlitz, H.W.: The effects of morphine on the release of noradrenaline from the cat isolated nictitating membrane and the guinea-pig ileum myenteric plexus-longitudinal muscle preparation. Brit. J. Pharmacol. 53, 505–512 (1975)
Henderson, G., Hughes, J., Thompson, J.W.: The variation of noradrenaline output with frequency of nerve stimulation and the effect of morphine on the cat nictitating membrane and on the guinea-pig myenteric plexus. Brit. J. Pharmacol. 46, 524–525P (1972b)
Henseling, M., Eckert, E., Trendelenburg, U.: The effect of cocaine on the distribution of labelled noradrenaline in rabbit aortic strips and on efflux of radioactivity from the strips. Naunyn-Schmiedeberg's Arch. Pharmacol. 292, 231–241 (1976)
Hertting, G., Axelrod, J.: Fate of tritiated noradrenaline at the sympathetic nerve-endings. Nature (Lond.) 192, 172–173 (1961)
Hertting, G., Schiefthaler, T.: Beziehung zwischen Durchflußgröße und Noradrenalinfreisetzung bei Nervenreizung der isoliert durchströmten Katzenmilz. Naunyn-Schmiedebergs Arch. exp. Path. Pharmakol. 246, 13–14 (1963)
Hertting, G., Suko, J.: Influence of angiotensin, vasopressin or changes in flow rate on vasoconstriction, changes in volume and (3H)-noradrenaline release following postganglionic sympathetic nerve stimulation in the isolated cat spleen. Brit. J. Pharmacol. 26, 686–696 (1966)
Hertting, G., Widhalm, S.: Über den Mechanismus der Noradrenalin-Freisetzung aus sympathischen Nervenendigungen. Naunyn-Schmiedebergs Arch. exp. Path. Pharmakol. 250, 257–258 (1965)
Herz, A., Teschemacher, H.J.: Activities and sites of antinociceptive action of morphine-like analgesics and kinetics of distribution following intravenous, intracerebral and intraventricular application. Advanc. Drug Res. 6, 79–119 (1971)
Hitzemann, R.J., Loh, H.H.: Effect of morphine on the transport of dopamine into mouse brain slices. Europ. J. Pharmacol. 21, 121–129 (1973)
Hoffmann, F., Hoffmann, E.J., Middleton, S., Talesnik, J.: The stimulating effect of acetylcholine on the mammalian heart and the liberation of an epinephrine-like substance by the isolated heart. Amer. J. Physiol. 144, 189–198 (1945)
Horton, E.W.: Prostaglandins at adrenergic nerve-endings. Brit. med. Bull. 29, 148–151 (1973)
Hoszowska, A., Panczenko, B.: Effects of inhibition of prostaglandin biosynthesis on noradrenaline release from isolated perfused spleen of the cat. Pol. J. Pharmacol. Pharm. 26, 137–142 (1974)
Hotta, Y.: Some properties of the junctional and extrajunctional receptors in the vas deferens of the guinea-pig. Agents Actions 1, 69–77 (= (13)-(21)) (1969)
Howd, R.A., Horita, A.: The effects of drugs on accumulation and release of catecholamines in rat brain slices. Arch. int. Pharmacodyn. 218, 231–238 (1975)
Hsu, C.Y., Westfall, T.C.: Mechanism of the release of 3H-norepinephrine (NE) induced by amino-phylline in the perfused guinea-pig heart. Fed. Proc. 32, 784 Abs (1973)
Hubbard, J.I.: Microphysiology of vertebrate neuromuscular transmission. Physiol. Rev. 53, 674–723 (1973)
Hubbard, J.I., Quastel, D.M.J.: Micropharmacology of vertebrate neuromuscular transmission. Ann. Rev. Pharmacol. 13, 199–216 (1973)
Hughes, J.: Evaluation of mechanisms controlling the release and inactivation of the adrenergic transmitter in the rabbit portal vein and vas deferens. Brit. J. Pharmacol. 44, 472–491 (1972)
Hughes, J.: Inhibition of noradrenaline release by lysergic acid diethylamide. Brit. J. Pharmacol. 49, 706–708 (1973)
Hughes, J., Kosterlitz, H.W., Leslie, F.M.: Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antagonist potencies of narcotic analgesics. Brit. J. Pharmacol. 53, 371–381 (1975a)
Hughes, J., Roth, R.H.: Enhanced release of transmitter during sympathetic nerve stimulation in the presence of angiotensin. Brit. J. Pharmacol. 37, 516–517P (1969)
Hughes, J., Roth, R.H.: Evidence that angiotensin enhances transmitter release during sympathetic nerve stimulation. Brit. J. Pharmacol. 41, 239–255 (1971)
Hughes, J., Roth, R.H.: Variation in noradrenaline output with changes in stimulus frequency and train length: Role of different noradrenaline pools. Brit. J. Pharmacol. 51, 373–381 (1974)
Hughes, J., Smith, T.W., Kosterlitz, H.W., Fothergill, L.A., Morgan, B.A., Morris, H.R.: Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature (Lond.) 258, 577–579 (1975b)
Hume, W.R., Lande, I.S. de la, Waterson, J.G.: Effect of acetylcholine on the response of the isolated rabbit ear artery to stimulation of the perivascular sympathetic nerves. Europ. J. Pharmacol. 17, 227–233 (1972)
Hunt, G.E., Atrens, D.M., Chesher, G.B., Becker, F.T.: α-Noradrenergic modulation of hypothalamic self-stimulation: Studies employing clonidine, 1-phenylephrine and α-methyl-p-tyrosine. Europ. J. Pharmacol. 37, 105–111 (1976)
Ilhan, M., Long, J.P.: Inhibition of the sympathetic nervous system by dopamine. Arch. int. Pharmacodyn. 216, 4–10 (1975)
Ilhan, M., Long, J.P., Cannon, J.G.: Inhibition of responses to stimulation of the cardioaccelerator nerves of the cat by N.N-dimethyldopamine and apomorphine. Arch. int. Pharmacodyn. 212, 247–254 (1974)
Ilhan, M., Long, J.P., Cannon, J.G.: Bulbocapnine's ability to antagonize the adrenergic inhibitory action of dopamine and analogs. Europ. J. Pharmacol. 33, 13–18 (1975)
Ilhan, M., Long, J.P., Cannon, J.G.: Effects of some dopamine analogs and haloperidol on response to stimulation of adrenergic nerves using cat atria in vitro. Arch. int. Pharmacodyn. 219, 193–204 (1976)
Illés, P., Hadházy, P., Torma, Z., Vizi, E.S., Knoll, J.: The effect of number of stimuli and rate of stimulation on the inhibition by PGE1 of adrenergic transmission. Europ. J. Pharmacol. 24, 29–36 (1973)
Illés, P., Vizi, E.S., Knoll, J.: Adrenergic neuroeffector junctions sensitive and insensitive to the effect of PGE1. Pol. J. Pharmacol. Pharm. 26, 127–136 (1974)
Iversen, L.L.: Uptake mechanisms for biogenic amines. In: Iversen, L.L., Iversen, S.D., Snyder, S.H. (eds.), Handbook of Psychopharmacology, Vol. 3, pp. 381–442. New York-London: Plenum Press 1975
Izumi, F., Oka, M., Kashimoto, T.: Possible role of cyclic-3′,5′-adenosine monophosphate in the release of catecholamines from the adrenal medulla. Med. J. Osaka Univ. 21, 241–249 (1971)
Jaanus, S.D., Rubin, R.P.: Analysis of the role of cyclic adenosine 3′,5′-monophosphate in catecholamine release. J. Physiol. (Lond.) 237, 465–476 (1974)
Jang, C.S.: The potentiation and paralysis of adrenergic effects by ergotoxine and other substances. J. Pharmacol. exp. Ther. 71, 87–94 (1941)
Janowsky, D.S., Davis, J.M., Fann, W.E., Freeman, J., Nixon, R., Michelakis, A.A.: Angiotensin effect on uptake of norepinephrine by synaptosomes. Life Sci. 11, I, 1–11 (1972)
Jenkins, D.A., Marshall, I., Nasmyth, P.A.: Is morphine inhibition of the twitch response of the mouse vas deferens mediated via noradrenaline? Brit. J. Pharmacol. 55, 267–268P (1975)
Jhamandas, K., Phillis, J.W., Pinsky, C.: Effects of narcotic analgesics and antagonists on the in vivo release of acetylcholine from the cerebral cortex of the cat. Brit. J. Pharmacol. 43, 53–66 (1971)
Johnson, D.G., Thoa, N.B., Weinshilboum, R., Axelrod, J., Kopin, I.J.: Enhanced release of dopamine-β-hydroxylase from sympathetic nerves by calcium and phenoxybenzamine and its reversal by prostaglandins. Proc. nat. Acad. Sci. (Wash.) 68, 2227–2230 (1971)
Junstad, M., Wennmalm, Å.: Increased renal excretion of noradrenaline in rats after treatment with prostaglandin synthesis inhibitor indomethacin. Acta physiol. scand. 85, 573–576 (1972)
Junstad, M., Wennmalm, Å.: On the release of prostaglandin E2 from the rabbit heart following infusion of noradrenaline. Acta physiol. scand. 87, 573–574 (1973a)
Junstad, M., Wennmalm, Å.: Prostaglandin mediated inhibition of noradrenaline release at different nerve impulse frequencies. Acta physiol. scand., 89, 544–549 (1973b)
Junstad, M., Wennmalm, Å.: Release of prostaglandin from the rabbit isolated heart following vagal nerve stimulation or acetylcholine infusion. Brit. J. Pharmacol. 52, 375–379 (1974)
Kadowitz, P.J., Sweet, C.S., Brody, M.J.: Differential effects of prostaglandins E1, E2, F1α and F2α adrenergic vasoconstriction in the dog hindpaw. J. Pharmacol. exp. Ther. 177, 641–649 (1971)
Kadowitz, P.J., Sweet, C.S., Brody, M.J.: Enhancement of sympathetic neurotransmission by prostaglandin F2α in the cutaneous vascular bed of the dog. Europ. J. Pharmacol. 18, 189–194 (1972)
Kaneko, Y., Takeda, T., Nakajima, K., Ueda, H.: Effect of angiotensin on the pressor response to tyramine in normotensive subjects and hypertensive patients. Circulat. Res. 19, 673–680 (1966)
Kao, C.Y., McCullough, J.R.: Electrophysiological properties of splenic nerve in relation to norepinephrine overflow. J. Pharmacol. exp. Ther. 185, 49–59 (1973)
Kato, A.C., Collier, B., Ilson, D., Wright, J.M.: The effect of atropine upon acetylcholine release from cat superior cervical ganglia and rat cortical slices: Measurement by a radio-enzymic method. Canad. J. Physiol. Pharmacol. 53, 1050–1057 (1975)
Kaumann, A.J.: Adrenergic receptors in heart muscle: Relations among factors influencing the sensitivity of the cat papillary muscle to catecholamines. J. Pharmacol. exp. Ther. 173, 383–398 (1970)
Kayaalp, S.O., Türker, R.K.: Effect of hemicholinium (HC-3) on the catecholamine releasing action of prostaglandin E1. Europ. J. Pharmacol. 3, 139–142 (1968)
Kehr, W., Carlsson, A., Lindqvist, M., Magnusson, T., Atack, C.: Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity. J. Pharm. Pharmacol. 24, 744–747 (1972)
Kennedy, B.L., West, T.C.: Effect of morphine on electrically-induced release of autonomic mediators in the rabbit sinoatrial node. J. Pharmacol. exp. Ther. 157, 149–158 (1967)
Khairallah, P.A.: Action of angiotensin on adrenergic nerve endings: inhibition of norepinephrine uptake. Fed. Proc. 31, 1351–1357 (1972)
Kilbinger, H., Lindmar, R., Löffelholz, K., Muscholl, E., Patil, P.N.: Storage and release of false transmitters after infusion of (+)-and (−)-α-methyldopamine. Naunyn-Schmiedebergs Arch. Pharmakol. 271, 234–248 (1971)
Kilbinger, H., Wagner, P.: Inhibition by oxotremorine of acetylcholine resting release from guinea pig-ileum longitudinal muscle strips. Naunyn-Schmiedeberg's Arch. Pharmacol. 287, 47–60 (1975)
Kiran, B.K., Khairallah, P.A.: Angiotensin and norepinephrine efflux. Europ. J Pharmacol. 6, 102–108 (1969)
Kirpekar, S.M., Cervoni, P.: Effect of cocaine, phenoxybenzamine and phentolamine on the catecholamine output from spleen and adrenal medulla. J. Pharmacol. exp. Ther. 142, 59–70 (1963)
Kirpekar, S.M., Furchgott, R.F., Wakade, A.R., Prat, J.C.: Inhibition by sympathomimetic amines of the release of norepinephrine evoked by nerve stimulation in the cat spleen. J. Pharmacol. exp. Ther. 187, 529–538 (1973)
Kirpekar, S.M., Misu, Y.: Release of noradrenaline by splenic nerve stimulation and its dependence on calcium. J. Physiol. (Lond.) 188, 219–234 (1967)
Kirpekar, S.M., Prat, J.C., Puig, M., Wakade, A.R.: Modification of the evoked release of noradrenaline from the perfused cat spleen by various ions and agents. J. Physiol. (Lond.) 221, 601–615 (1972a)
Kirpekar, S.M., Prat, J.C., Wakade, A.R.: Effect of calcium on the relationship between frequency of stimulation and release of noradrenaline from the perfused spleen of the cat. Naunyn-Schmiedeberg's Arch. Pharmacol. 287, 205–212 (1975)
Kirpekar, S.M., Puig, M.: Effect of flow-stop on noradrenaline release from normal spleens and spleens treated with cocaine, phentolamine or phenoxybenzamine. Brit. J. Pharmacol. 43, 359–369 (1971)
Kirpekar, S.M., Wakade, A.R.: Release of noradrenaline from the cat spleen by potassium. J. Physiol. (Lond.) 194, 595–608 (1968)
Kirpekar, S.M., Wakade, A.R.: Effect of β-haloalkylamines and ephedrine on noradrenaline release from the intact spleen of the cat. Brit. J. Pharmacol. 39, 533–541 (1970)
Kirpekar, S.M., Wakade, A.R., Steinsland, O.S., Prat, J.C., Furchgott, R.F.: Inhibition of the evoked release of norepinephrine (NE) by sympathomimetic amines. Fed. Proc. 31, 566 Abs (1972b)
Knoll, J., Vizi, E.S.: Effect of frequency of stimulation on the inhibition by noradrenaline of the acetylcholine output from parasympathetic nerve terminals. Brit. J. Pharmacol. 42, 263–272 (1971)
Kobinger, W.: Über den Wirkungsmechanismus einer neuen antihypertensiven Substanz mit Imidazolinstruktur. Naunyn-Schmiedebergs Arch. Pharmakol. exp. Path. 258, 48–58 (1967)
Kobinger, W.: Medicinal chemistry related to the central regulation of blood pressure, II. Pharmacological part. In: Maas, J. (ed.), Medicinal Chemistry IV. Proceedings of the 4th International Symposium on Medicinal Chemistry, pp. 107–120. Amsterdam-Oxford-New York: Elsevier 1974
Kobinger, W., Pichler, L.: Evidence for direct α-adrenoceptor stimulation of effector neurons in cardiovascular centers by clonidine. Europ. J. Pharmacol. 27, 151–154 (1974)
Kobinger, W., Pichler, L.: Investigation into some imidazoline compounds, with respect to peripheral α-adrenoceptor stimulation and depression of cardiovascular centers. Naunyn-Schmiedeberg's Arch. Pharmacol. 291, 175–191 (1975)
Kobinger, W., Walland, A.: Involvement of adrenergic receptors in central vagus activity. Europ. J. Pharmacol. 16, 120–122 (1971)
Kopin, I.J.: Metabolic degradation of catecholamines. The relative importance of different pathways under physiological conditions and after administration of drugs. In: Blaschko, H., Muscholl, E. (eds.), Catecholamines. Handbuch der experimentellen Pharmakologie, Vol. 33, pp. 270–282. Berlin-Heidelberg-New York: Springer 1972
Korf, J., Bunney, B.S., Aghajanian, G.K.: Noradrenergic neurons: morphine inhibition of spontaneous activity. Europ. J. Pharmacol. 25, 165–169 (1974)
Kosterlitz, H.W., Hughes, J.: Some thoughts on the significance of enkephalin, the endogenous ligand. Life Sci. 17, 91–96 (1975)
Kosterlitz, H.W., Lees, G.M.: Interrelationships between adrenergic and cholinergic mechanisms. In: Blaschko, H., Muscholl, E. (eds.), Catecholamines. Handbuch der experimentellen Pharmakologie, Vol. 33, pp. 762–812. Berlin-Heidelberg-New York: Springer 1972
Kosterlitz, H.W., Lydon, R.J., Watt, A.J.: The effects of adrenaline, noradrenaline and isoprenaline on inhibitory α-and β-adrenoceptors in the longitudinal muscle of the guinea-pig ileum. Brit. J. Pharmacol. 39, 398–413 (1970)
Kosterlitz, H.W., Taylor, D.W.: The effect of morphine on vagal inhibition of the heart. Brit. J. Pharmacol. 14, 209–214 (1959)
Kosterlitz, H.W., Wallis, D.I.: The action of morphine-like drugs on impulse transmission in mammalian nerve fibres. Brit. J. Pharmacol. 22, 499–510 (1964)
Krauss, K.R., Carpenter, D.O., Kopin, I.J.: Acetylcholine-induced release of norepinephrine in the presence of tetrodotoxin. J. Pharmacol. exp. Ther. 173, 416–421 (1970)
Krnjević, K.: Chemical nature of synaptic transmission in vertebrates. Physiol. Rev. 54, 418–540 (1974)
Kroneberg, G., Oberdorf, A., Hoffmeister, F., Wirth, W.: Zur Pharmakologie von 2-(2,6-Dimethyl-phenylamino)-4H-5,6-dihydro-1,3-thiazin (Bayer 1470), eines Hemmstoffes adrenergischer und cholinergischer Neurone. Naunyn-Schmiedebergs Arch. Pharmakol. exp. Path. 256, 257–280 (1967)
Kuchii, M., Miyahara, J.T., Shibata, S.: (3H)-adenine nucleotide and (3H)-noradrenaline release evoked by electrical field stimulation, perivascular nerve stimulation and nicotine from the taenia of the guinea-pig caecum. Brit. J. Pharmacol. 49, 258–267 (1973)
Langer, S.Z.: The effects of phenoxybenzamine on metabolism of 3H-noradrenaline released from the isolated nictitating membrane. Brit. J. Pharmacol. 34, 222–223P (1968)
Langer, S.Z.: The metabolism of (3H)noradrenaline released by electrical stimulation from the isolated nictitating membrane of the cat and from the vas deferens of the rat. J. Physiol. (Lond.) 208, 515–546 (1970)
Langer, S.Z.: The regulation of transmitter release elicited by nerve stimulation through a presynaptic feed-back mechanism. In: Usdin, E., Snyder, S.H. (eds.), Frontiers in Catecholamine Research, pp. 543–549. New York: Pergamon Press 1973a
Langer, S.Z.: Effects of dopamine on the presynaptic negative feedback mechanism that regulates noradrenaline release by nerve stimulation. In: Proceedings of the 2nd Meeting on Adrenergic Mechanisms, Porto, 1973b, pp. 49–50
Langer, S.Z.: Selective metabolic pathways for noradrenaline in the peripheral and in the central nervous system. Med. Biol. 52, 372–383 (1974a)
Langer, S.Z.: Presynaptic regulation of catecholamine release. Biochem. Pharmacol. 23, 1793–1800 (1974b)
Langer, S.Z.: Prejunctional regulatory mechanisms for noradrenaline release elicited by nerve stimulation. In: Abstracts of the symposium Chemical Tools in Catecholamine Research, Göteborg, 1975
Langer, S.Z., Adler, E., Enero, M.A., Stefano, F.J.E.: The role of the alpha receptor in regulating noradrenaline overflow by nerve stimulation. Proc. XXVth Int. Congr. Physiol. Sci., Munich, 1971, p. 335
Langer, S.Z., Dubocovich, M.L., Celuch, S.M.: Prejunctional regulatory mechanisms for noradrenaline release elicited by nerve stimulation. In: Almgren, O., Carlsson, A., Engel, J. (eds.), Chemical Tools in Catecholamine Research, Vol. 2, pp. 183–191. Amsterdam-Oxford: North-Holland 1975a
Langer, S.Z., Enero, M.A.: The potentiation of responses to adrenergic nerve stimulation in the presence of cocaine: Its relationship to the metabolic fate of released norepinephrine. J. Pharmacol. exp. Ther. 191, 431–443 (1974)
Langer, S.Z., Enero, M.A., Adler-Graschinsky, E., Dubocovich, M.L., Celuchi, S.M.: Presynaptic regulatory mechanisms for noradrenaline release by nerve stimulation. In: Davies, D.S., Reid, J.L. (eds.), Central Action of Drugs in Blood Pressure Regulation, pp. 133–150. Tunbridge Wells: Pitman 1975b
Langer, S.Z., Enero, M.A., Stefano, F.J.E., Rothlin, R.P.: Acciones de la fenoxibenzamina sobre la liberación de noradrenalina por estimulación nerviosa en la membrana nictitante aislada de gato. Medicina (B. Aires) 30, 557–558 (1970)
Langer, S.Z., Granata, A.R., Enero, M.A., Krieger, E.M.: Overflow of labelled transmitter elicited by nerve stimulation in the perfused mesenteric arteries of rats after the development of neurogenic hypertension. Blood Vessels 12, 368–369 (1975c)
Langer, S.Z., Rubio, M.C.: Effects of noradrenaline metabolites on the adrenergic receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 276, 71–88 (1973)
Langer, S.Z., Stefano, F.J.E., Enero, M.A.: Pre-and postsynaptic origin of the norepinephrine metabolites formed during transmitter release elicited by nerve stimulation. J. Pharmacol. exp. Ther. 183, 90–102 (1972)
Langer, S.Z., Vogt, M.: Noradrenaline release from isolated muscles of the nictitating membrane of the cat. J. Physiol. (Lond.) 214, 159–171 (1971)
Langley, A.E., Gardier, R.W.: Regulation of norepinephrine and dopamine-β-hydroxylase release during sympathetic nerve stimulation. Fed. Proc. 33, 523 Abs (1974)
Lees, G.M., Kosterlitz, H.W., Waterfield, A.A.: Characteristics of morphine-sensitive release of neuro-transmitter substances. In: Kosterlitz, H.W., Collier, H.O.J., Villareal, J.E. (eds.), Agonist and Antagonist Actions of Narcotic Analgesic Drugs, pp. 142–152. London-Basingstoke: Macmillan 1972
Lembeck, F., Juan, H.: Are there therapeutic indications of intravenous injection of calcium gluconate? Arzneimittelforsch. 25, 1570–1574 (1975)
Levin, J.A.: The uptake and metabolism of 3H-l-and 3H-dl-norepinephrine by intact rabbit aorta and by isolated adventitia and media. J. Pharmacol. exp. Ther. 190, 210–226 (1974)
Levy, M.N., Blattberg, B.: Effect of vagal stimulation on the overflow of norepinephrine into the coronary sinus during cardiac sympathetic nerve stimulation in the dog. Circulat. Res. 38, 81–85 (1976)
Liao, J.C., Zimmerman, B.G., Bergen, F.H. van: Adrenergic responses in canine cutaneous vasculature during acute hemorrhagic hypotension. Amer. J. Physiol. 228, 752–755 (1975)
Lindmar, R., DeSantis, V.P.: The significance of noradrenaline and adrenaline as adrenergic transmitters in the chicken. Naunyn-Schmiedeberg's Arch. Pharmacol. 282, R58 (1974)
Lindmar, R., Löffelholz, K., Muscholl, E.: Unterschiede zwischen Tyramin und Dimethylphenylpiperazin in der Ca++-Abhängigkeit und im zeitlichen Verlauf der Noradrenalin-Freisetzung am isolierten Kaninchenherzen. Experientia (Basel) 23, 933–934 (1967a)
Lindmar, R., Löffelholz, K., Muscholl, E.: A muscarinic mechanism inhibiting the release of noradrenaline from peripheral adrenergic nerve fibres by nicotinic agents. Brit. J. Pharmacol. 32, 280–294 (1968)
Lindmar, R., Muscholl, E.: Die Wirkung von Cocain, Guanethidin, Reserpin, Hexamethonium, Tetracain und Psicain auf die Noradrenalin-Freisetzung aus dem Herzen. Naunyn-Schmiedeberg's Arch. exp. Path. Pharmakol. 242, 214–227 (1961)
Lindmar, R., Muscholl, E., Sprenger, E.: Funktionelle Bedeutung der Freisetzung von Dihydroxyephedrin und Dihydroxypseudoephedrin als „falschen“ sympathischen Überträgerstoffen am Herzen. Naunyn-Schmiedebergs Arch. Pharmakol. exp. Path. 256, 1–25 (1967b)
Ljung, B., Åblad, B., Dahlöf, C., Henning, M., Hultberg, E.: Impaired vasoconstrictor nerve function in spontaneously hypertensive rats after long-term treatment with propranolol and metroprolol. Blood Vessels 12, 311–315 (1975)
Löffelholz, K.: Untersuchungen über die Noradrenalin-Freisetzung durch Acetylcholin am perfundierten Kaninchenherzen. Naunyn-Schmiedebergs Arch. Pharmakol. exp. Path. 258, 108–122 (1967)
Löffelholz, K.: Autoinhibition of nicotinic release of noradrenaline from postganglionic sympathetic nerves. Naunyn-Schmiedebergs Arch. Pharmakol. 267, 49–63 (1970a)
Löffelholz, K.: Nicotinic drugs and postganglionic sympathetic transmission. Naunyn-Schmiedebergs Arch. Pharmakol. 267, 64–73 (1970b)
Löffelholz, K.: Muscarinic inhibition of adrenergic neurotransmission. Gordon Conference on Catecholamines, Andover, New Hampshire (1975)
Löffelholz, K., Lindmar, R., Muscholl, E.: Der Einfluß von Atropin auf die Noradrenalin-Freisetzung durch Acetylcholin. Naunyn-Schmiedebergs Arch. Pharmakol. exp. Path. 257, 308 (1967)
Löffelholz, K., Muscholl, E.: A muscarinic inhibition of the noradrenaline release evoked by postganglionic sympathetic nerve stimulation. Naunyn-Schmiedebergs Arch. Pharmakol. 265, 1–15 (1969)
Löffelholz, K., Muscholl, E.: Inhibition by parasympathetic nerve stimulation of the release of the adrenergic transmitter. Naunyn-Schmiedebergs Arch. Pharmakol. 267, 181–184 (1970)
Long, J.P., Heintz, S., Cannon, J.G., Kim, J.: Inhibition of the sympathetic nervous system by 5,6-dihydroxy-2-dimethylamino tetralin (M-7), apomorphine and dopamine. J. Pharmacol. exp. Ther. 192, 336–342 (1975)
Luchelli-Fortis, M.A., Langer, S.Z.: Selective inhibition by hydrocortisone of 3H-normetanephrine formation during 3H-transmitter release elicited by nerve stimulation in the isolated nerve-muscle preparation of the cat nictitating membrane. Naunyn-Schmiedeberg's Arch. Pharmacol. 287, 261–275 (1975)
Malik, K.U., Ling, G.M.: The effect of 1,1-dimethyi-4-phenylpiperazinium on the response of mesenteric arteries to sympathetic nerve stimulation. J. Pharm. Pharmacol. 21, 514–519 (1969a)
Malik, K.U., Ling, G.M.: Modification by acetylcholine of the response of rat mesenteric arteries to sympathetic stimulation. Circulat. Res. 25, 1–9 (1969b)
Malik, K.U., McGiff, J.C.: Modulation by prostaglandins of adrenergic transmission in the isolated perfused rabbit and rat kidney. Circulat. Res. 36, 599–609 (1975)
Malik, K.U., Nasjletti, A.: Facilitation of adrenergic transmission by locally generated angiotensin II in rat mesenteric arteries. Circulat. Res. 38, 26–30 (1976)
Malméjac, J.: Action of adrenaline on synaptic transmission and on adrenal medullary secretion. J. Physiol. (Lond.) 130, 497–512 (1955)
McCubbin, J.W., Page, I.H.: Renal pressor system and neurogenic control of arterial pressure. Circulat. Res. 12, 553–559 (1963)
McCulloch, M.W., Rand, M.J., Story, D.F.: Inhibition of 3H-noradrenaline release from sympathetic nerves of guinea-pig atria by a presynaptic α-adrenoceptor mechanism. Brit. J. Pharmacol. 46, 523–524P (1972)
McCulloch, M.W., Rand, M.J., Story, D.F.: Evidence for a dopaminergic mechanism for modulation of adrenergic transmission in the rabbit ear artery. Brit. J. Pharmacol. 49, 141–142P (1973)
Miele, E.: Lack of effect of prostaglandins E1 and F1α on adreno-medullary catecholamine secretion evoked by various agents. In: Mantegazza, P., Horton, E.W. (eds.), Prostaglandins, Peptides and Amines, pp. 85–93. London-New York: Academic Press 1969
Moawad, A., Hedqvist, P., Bygdeman, M.: Noradrenaline release following nerve stimulation and its modification by prostaglandin E2 in human and rabbit oviduct. Acta physiol. scand. 95, 142–144 (1975)
Montel, H., Starke, K.: Effects of narcotic analgesics and their antagonists on the rabbit isolated heart and its adrenergic nerves. Brit. J. Pharmacol. 49, 628–641 (1973)
Montel, H., Starke, K., Taube, H.D.: Morphine tolerance and dependence in noradrenaline neurones of the rat cerebral cortex. Naunyn-Schmiedeberg's Arch. Pharmacol. 288, 415–426 (1975a)
Montel, H., Starke, K., Taube, H.D.: Influence of morphine and naloxone on the release of noradrenaline from rat cerebellar cortex slices. Naunyn-Schmiedeberg's Arch. Pharmacol. 288, 427–433 (1975b)
Montel, H., Starke, K., Taube, H.D.: Narcotic analgesics and central noradrenaline neurones. An in vitro study. In: Abstracts of the symposium Acute Effects of Narcotic Analgesics, Nokkala, Finland, 1975c, pp. 45–47
Montel, H., Starke, K., Weber, F.: Influence of morphine and naloxone on the release of noradrenaline from rat brain cortex slices. Naunyn-Schmiedeberg's Arch. Pharmacol. 283, 357–369 (1974a)
Montel, H., Starke, K., Weber, F.: Influence of fentanyl, levorphanol and pethidine on the release of noradrenaline from rat brain cortex slices. Naunyn-Schmiedeberg's Arch. Pharmacol. 283, 371–377 (1974b)
Morishita, H., Furukawa, T.: Possible mechanisms involved in the depressor response to dopamine. Arch. int. Pharmacodyn. 212, 317–327 (1974)
Mujić, M., Rossum, J.M. van: Comparative pharmacodynamics of sympathomimetic imidazolines; studies on intestinal smooth muscle of the rabbit and the cardiovascular system of the cat. Arch. int. Pharmacodyn. 155, 432–449 (1965)
Mullin, W.J., Phillis, J.W., Pinsky, C.: Morphine enhancement of acetylcholine release from the brain in unanaesthetized cats. Europ. J. Pharmacol. 22, 117–119 (1973)
Musacchio, J.M.: Enzymes involved in the biosynthesis and degradation of catecholamines. In: Iversen, L.L., Iversen, S.D., Snyder, S.H. (eds.), Handbook of Psychopharmacology, Vol. 3, pp. 1–35. New York-London: Plenum Press 1975
Muscholl, E.: Release of catecholamines from the heart. In: Mechanisms of Release of Biogenic Amines, pp. 247–260. Oxford: Pergamon Press 1966
Muscholl, E.: Cholinomimetic drugs and release of the adrenergic transmitter. In: Schumann, H.J., Kroneberg, G. (eds.), New Aspects of Storage and Release Mechanisms of Catecholamines, pp. 168–186. Berlin-Heidelberg-New York: Springer 1970
Muscholl, E.: Regulation of catecholamine release. The muscarinic inhibitory mechanism. In: Usdin, E., Snyder, S.H. (eds.), Frontiers in Catecholamine Research, pp. 537–542. New York: Pergamon Press 1973a
Muscholl, E.: Muscarinic inhibition of the norepinephrine release from peripheral sympathetic fibres. In: Pharmacology and the Future of Man. Proc. 5th Int. Congr. Pharmacol., Vol. 4, pp. 440–457. Basel: Karger 1973b
Muscholl, E.: Introduction. In: Proceedings of the 2nd Meeting on Adrenergic Mechanisms, Porto, 1973c, pp. 33–39
Muscholl, E., Maître, L.: Release by sympathetic stimulation of α-methylnoradrenaline stored in the heart after administration of α-methyldopa. Experientia (Basel) 19, 658–659 (1963)
Muscholl, E., Ritzel, H., Rössler, K.: The time course of noradrenaline release caused by high potassium-low sodium solution. Effects of methacholine or decrease of the calcium ion concentration. Brit. J. Pharmacol. 55, 248 P (1975)
Mylecharane, E.J., Raper, C.: Further studies on the adrenergic neuron blocking activity of some β-adrenoceptor antagonists and guanethidine. J. Pharm. Pharmacol. 25, 213–220 (1973)
Nedergaard, O.A., Bevan, J.A.: Nicotine and nicotine monomethiodide induced potentiation of adrenergic neuroeffector transmission in a blood vessel. In: Abstr. 4th Int. Congr. Pharmacol., Basel, 1969a, p. 144
Nedergaard, O.A., Bevan, J.A.: Effects of nicotine, dimethylphenylpiperazinium and cholinergic blocking agents at adrenergic nerve endings of the rabbit pulmonary artery. J. Pharmacol. exp. Ther. 168, 127–136 (1969b)
Nedergaard, O.A., Schrold, J.: Release of 3H-noradrenaline from incubated and superfused rabbit pulmonary artery. Acta physiol. scand. 89, 296–305 (1973)
Needleman, P., Douglas, J.R., Jakschik, B., Stoecklein, P.B., Johnson, E.M.: Release of renal prostaglandin by catecholamines: Relationship to renal endocrine function. J. Pharmacol. exp. Ther. 188, 453–460 (1974)
Nishi, S.: Cholinergic and adrenergic receptors at sympathetic preganglionic nerve terminals. Fed. Proc. 29, 1957–1965 (1970)
Noon, J.P., Roth, R.H.: Some physiological and pharmacological characteristics of the stimulus induced release of norepinephrine from the rabbit superior cervical ganglion. Naunyn-Schmiedeberg's Arch. Pharmacol. 291, 163–174 (1975)
North, R.A., Henderson, G.: Action of morphine on guinea-pig myenteric plexus and mouse vas deferens studied by intracellular recording. Life Sci. 17, 63–66 (1975)
Nueten, J.M. van, Janssen, P.A.J., Fontaine, J.: Unexpected reversal effects of naloxone on the guinea pig ileum. Life Sci. 18, 803–809 (1976)
Otten, U., Mueller, R.A., Thoenen, H.: Effect of hypophysectomy on cAMP changes in rat adrenal medulla evoked by catecholamines and carbamylcholine. Naunyn-Schmiedeberg's Arch. Pharmacol. 289, 157–170 (1975)
Paalzow, G., Paalzow, L.: Clonidine antinociceptive activity: Effects of drugs influencing central monoaminergic and cholinergic mechanisms in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 292, 119–126 (1976)
Paalzow, L.: Analgesia produced by clonidine in mice and rats. J. Pharm. Pharmacol. 26, 361–363 (1974)
Pacha, W., Salzmann, R.: Inhibition of the re-uptake of neuronally liberated noradrenaline and α-receptor blocking action of some ergot alkaloids. Brit. J. Pharmacol. 38, 439–440P (1970)
Pacha, W., Salzmann, R., Scholtysik, G.: Inhibitory effects of clonidine and BS 100–141 on responses to sympathetic nerve stimulation in cats and rabbits. Brit. J. Pharmacol. 53, 513–516 (1975)
Panisset, J.C.: Cholinergic effects of angiotensin and bradykinin. Advanc. exp. Med. Biol. 2, 620–625 (1968)
Panisset, J.C., Bourdois, P.: Effect of angiotensin on the response to noradrenaline and sympathetic nerve stimulation, and on 3H-noradrenaline uptake in cat mesenteric blood vessels. Canad. J. Physiol. Pharmacol. 46, 125–131 (1968)
Park, M.K., Dyer, D.C., Vincenzi, F.F.: Prostaglandin E2 and its antagonists: Effects on autonomic transmission in the isolated sino-atrial node. Prostaglandins 4, 717–730 (1973)
Paton, D.M.: Mechanism of K+-induced release of cytoplasmic noradrenaline from adrenergic nerves. Brit. J. Pharmacol. 55, 247P (1975)
Paton, D.M. (ed.): The Mechanism of Neuronal and Extraneuronal Transport of Catecholamines. New York: Raven Press 1976
Paton, W.D.M.: The action of morphine and related substances on contraction and on acetylcholine output of coaxially stimulated guinea-pig ileum. Brit. J. Pharmacol. 12, 119–127 (1957)
Paton, W.D.M., Thompson, J.W.: The mechanism of action of adrenaline on the superior cervical ganglion of the cat. Proc. XIXth Int. Congr. Physiol. Sci., Montreal, 1953, pp. 664–665
Paton, W.D.M., Vizi, E.S.: The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea-pig ileum longitudinal muscle strip. Brit. J. Pharmacol. 35, 10–28 (1969)
Peach, M.J.: Stimulation of release of adrenal catecholamine by adenosine 3′∶5′-cyclic monophosphate and theophylline in the absence of extracellular Ca2+. Proc. nat. Acad. Sci. (Wash.) 69, 834–836 (1972)
Peach, M.J., Bumpus, F.M., Khairallah, P.A.: Inhibition of norepinephrine uptake in hearts by angiotensin II and analogs. J. Pharmacol. exp. Ther. 167, 291–299 (1969)
Peach, M.J., Ober, M.: Inhibition of angiotensin-induced adrenal catecholamine release by 8-substituted analogs of angiotensin II. J. Pharmacol. exp. Ther. 190, 49–58 (1974)
Peskar, B., Hertting, G.: Release of prostaglandins from isolated cat spleen by angiotensin and vasopressin. Naunyn-Schmiedeberg's Arch. Pharmacol. 279, 227–234 (1973)
Poisner, A.M.: Direct stimulant effect of aminophylline on catecholamine release from the adrenal medulla. Biochem. Pharmacol. 22, 469–476 (1973a)
Poisner, A.M.: Caffeine-induced catecholamine secretion: Similarity to caffeine-induced muscle contraction. Proc. Soc. exp. Biol. (N.Y.) 142, 103–105 (1973b)
Poisner, A.M.: Mechanisms of exocytosis. In: Usdin, E., Snyder, S.H. (eds.), Frontiers in Catecholamine Research, pp. 477–482. New York: Pergamon Press 1973c
Poisner, A.M., Douglas, W.W.: The need for calcium in adrenomedullary secretion evoked by biogenic amines, polypeptides, and muscarinic agents. Proc. Soc. exp. Biol. (N.Y.) 123, 62–64 (1966)
Polak, R.L.: Stimulating action of atropine on the release of acetylcholine by rat cerebral cortex in vitro. Brit. J. Pharmacol. 41, 600–606 (1971)
Porte, D., Robertson, R.P.: Control of insulin secretion by catecholamines, stress, and the sympathetic nervous system. Fed. Proc. 32, 1792–1796 (1973)
Potter, W.P. de, Chubb, I.W., Put, A., Schaepdryver, A.F. de: Facilitation of the release of noradrenaline and dopamine-β-hydroxylase at low stimulation frequencies by α-blocking agents. Arch. int. Pharmacodyn. 193, 191–197 (1971)
Poyart, C.F., Papayoanou, J., Nahas, G.G.: Effet de l'ouabaine et de 1'A.M.P. cyclique sur le débit en catécholamines de la surrénale isolée. J. Physiol. (Paris) 60, Suppl., 523 (1968)
Price, M.T.C., Fibiger, H.C.: Ascending catecholamine systems and morphine analgesia. Brain Res. 99, 189–193 (1975)
Rahwan, R.G., Borowitz, J.L., Miya, T.S.: The role of intracellular calcium in catecholamine secretion from the bovine adrenal medulla. J. Pharmacol. exp. Ther. 184, 106–118 (1973)
Rand, M.J., Hope, W., McCulloch, M.W., Story, D.F.: Interaction of pimozide with prejunctional dopamine receptors in the rabbit ear artery. Clin. exp. Pharmacol. Physiol. 2, 439–440 (1975a)
Rand, M.J., Story, D.F., Allen, G.S., Glover, A.B., McCulloch, M.W.: Pulse-to-pulse modulation of noradrenaline release through a prejunctional α-receptor auto-inhibitory mechanism. In: Usdin, E., Snyder, S.H. (eds.), Frontiers in Catecholamine Research, pp. 579–581. New York: Pergamon Press 1973
Rand, M.J., Story, D.F., McCulloch, M.W.: Inhibitory feedback modulation of adrenergic transmission. Clin. exp. Pharmacol. Physiol., Suppl. 2, 21–26 (1975b)
Rand, M.J., Varma, B.: The effects of cholinomimetic drugs on responses to sympathetic nerve stimulation and noradrenaline in the rabbit ear artery. Brit. J. Pharmacol. 38, 758–770 (1970)
Rasmussen, H.: Cell communication, calcium ion, and cyclic adenosine monophosphate. Science 170, 404–412 (1970)
Regoli, D., Park, W.K., Rioux, F.: Pharmacology of angiotensin. Pharmacol. Rev. 26, 69–123 (1974)
Reit, E.: Actions of angiotensin on the adrenal medulla and autonomic ganglia. Fed. Proc. 31, 1338–1343 (1972)
Richardson, J.A., Woods, E.F.: Release of norepinephrine from the isolated heart. Proc. Soc. exp. Biol. (N.Y.) 100, 149–151 (1959)
Robson, R.D., Antonaccio, M.J.: Effect of clonidine on responses to cardiac nerve stimulation as a function of impulse frequency and stimulus duration in vagotomized dogs. Europ. J. Pharmacol. 29, 182–186 (1974)
Rochette, L., Bralet, A.M., Bralet, J.: Influence de la clonidine sur la synthèse et la libération de la noradrénaline dans différentes structures cérébrales du rat. J. Pharmacol. (Paris) 5, 209–220 (1974)
Rosell, S., Kopin, I.J., Axelrod, J.: Fate of H3-noradrenaline in skeletal muscle before and following sympathetic stimulation. Amer. J. Physiol. 205, 317–321 (1963)
Ross, G.: Effects of intracoronary infusions of acetylcholine and nicotine on the dog heart in vivo. Brit. J. Pharmacol. 48, 612–619 (1973)
Roth, R.H.: Action of angiotensin on adrenergic nerve endings: Enhancement of norepinephrine biosynthesis. Fed. Proc. 31, 1358–1364 (1972)
Roth, R.H., Hughes, J.: Acceleration of protein synthesis by angiotensin-Correlation with angiotensin's effect on catecholamine biosynthesis. Biochem. Pharmacol. 21, 3182–3187 (1972)
Rubin, R.P.: The role of calcium in the release of neurotransmitter substances and hormones. Pharmacol. Rev. 22, 389–428 (1970)
Salt, P.J.: Inhibition of noradrenaline uptake2 in the isolated rat heart by steroids, clonidine and methoxylated phenylethylamines. Europ. J. Pharmacol. 20, 329–340 (1972)
Salzmann, R., Pacha, W., Taeschler, M., Weidmann, H.: The effect of ergotamine on humoral and neuronal actions in the nictitating membrane and spleen of the cat. Naunyn-Schmiedebergs Arch. Pharmakol. exp. Path. 261, 360–378 (1968)
Samuelsson, B., Wennmalm, Å.: Increased nerve stimulation induced release of noradrenaline from the rabbit heart after inhibition of prostaglandin synthesis. Acta physiol. scand. 83, 163–168 (1971)
Sanders, K.M., Ross, G.: Inhibition of in vivo neural vasoconstriction by exogenous catecholamines. Blood Vessels 12, 13–20 (1975)
Sanner, J.: Prostaglandin inhibition with a dibenzoxazepine hydrazide derivative and morphine. Ann. N.Y. Acad. Sci. 180, 396–406 (1971)
Sasa, M., Munekiyo, K., Takaori, S.: Morphine interference with noradrenaline-mediated inhibition from the locus coeruleus. Life Sci. 17, 1373–1380 (1975)
Schaumann, W.: Inhibition by morphine of the release of acetylcholine from the intestine of the guinea-pig. Brit. J. Pharmacol. 12, 115–118 (1957)
Schaumann, W.: Zusammenhänge zwischen der Wirkung der Analgetica und Sympathicomimetica auf den Meerschweinchen-Dünndarm. Naunyn-Schmiedeberg's Arch. exp. Path. Pharmakol. 233, 112–124 (1958)
Scheel-Krüger, J., Braestrup, C., Nielsen, M.: Feedback regulation of brain noradrenaline synthesis and release in vivo after treatment with amphetamines and tricyclic antidepressant drugs. In: Almgren, O., Carlsson, A., Engel, J. (eds.), Chemical Tools in Catecholamine Research, Vol. 2, pp. 227–234. Amsterdam-Oxford: North-Holland 1975
Schmitt, H., Schmitt, H.: α-Sympathomimetic drugs with centrally mediated hypotensive effect. In: Abstr. 4th Int. Congr. Pharmacol., Basel, 1969, pp. 315–316
Schmitt, H., Schmitt, H., Fenard, S.: Evidence for an α-sympathomimetic component in the effects of catapresan on vasomotor centres: Antagonism by piperoxane. Europ. J. Pharmacol. 14, 98–100 (1971)
Scholtysik, G., Lauener, H., Eichenberger, E., Bürki, H., Salzmann, R., Müller-Schweinitzer, E., Waite, R.: Pharmacological actions of the antihypertensive agent N-amidino-2-(2,6-dichlorophenyl)acetamide hydrochloride (BS 100–141). Arzneimittelforsch. 25, 1483–1491 (1975)
Schümann, H.J.: Discussion. In: Schümann, H.J., Kroneberg, G. (eds.), New Aspects of Storage and Release Mechanisms of Catecholamines, p. 210. Berlin-Heidelberg-New York: Springer 1970
Schümann, H.J., Philippu, A.: Untersuchungen zum Mechanismus der Freisetzung von Brenzcatechinaminen durch Tyramin. Naunyn-Schmiedeberg's Arch. exp. Path. Pharmakol. 241, 273–280 (1961)
Schümann, H.J., Starke, K., Werner, U.: Interactions of inhibitors of noradrenaline uptake and angiotensin on the sympathetic nerves of the isolated rabbit heart. Brit. J. Pharmacol. 39, 390–397 (1970a)
Schümann, H.J., Starke, K., Werner, U., Hellerforth, R.: The influence of angiotensin on the uptake of noradrenaline by the isolated heart of the rabbit. J. Pharm. Pharmacol. 22, 441–446 (1970b)
Schulz, R., Cartwright, C.: Effect of morphine on serotonin release from myenteric plexus of the guinea pig. J. Pharmacol. exp. Ther. 190, 420–430 (1974)
Scriabine, A., Stavorski, J.M.: Effect of clonidine on cardiac acceleration in vagotomized dogs. Europ. J. Pharmacol. 24, 101–104 (1973)
Scriabine, A., Stavorski, J., Wenger, H.C., Torchiana, M.L., Stone, C.A.: Cardiac slowing effects of clonidine (ST-155) in dogs. J. Pharmacol. exp. Ther. 171, 256–264 (1970)
Seeman, P., Lee, T.: Antipsychotic drugs: Direct correlation between clinical potency and presynaptic action on dopamine neurons. Science 188, 1217–1219 (1975)
Serck-Hanssen, G.: Effects of theophylline and propranolol on acetylcholine-induced release of adrenal medullary catecholamines. Biochem. Pharmacol. 23, 2225–2234 (1974)
Severs, W.B., Daniels-Severs, A.E.: Effects of angiotensin on the central nervous system. Pharmacol. Rev. 25, 415–449 (1973)
Severs, W.B., Summy-Long, J., Daniels-Severs, A., Connor, J.D.: Influence of adrenergic blocking drugs on central angiotensin effects. Pharmacol. 5, 205–214 (1971)
Sheys, E.M., Green, R.D.: A quantitative study of alpha adrenergic receptors in the spleen and aorta of the rabbit. J. Pharmacol. exp. Ther. 180, 317–325 (1972)
Simantov, R., Snyder, S.H.: Isolation and structure identification of a morphine-like peptide “enkephalin” in bovine brain. Life Sci. 18, 781–788 (1976)
Sjöstrand, N.O.: A note of the dual effect of prostaglandin E1 on the responses of the guinea-pig vas deferens to nerve stimulation. Experientia (Basel) 28, 431–432 (1972)
Sjöstrand, N.O.: Effects of acetylcholine and some other smooth muscle stimulants on the electrical and mechanical responses of the guinea-pig vas deferens to nerve stimulation. Acta physiol. scand. 89, 1–9 (1973a)
Sjöstrand, N.O.: Effects of adrenaline, noradrenaline and isoprenaline on the electrical and mechanical responses of the guinea-pig vas deferens to nerve stimulation. Acta physiol. scand. 89, 10–18 (1973b)
Sjöstrand, N.O., Swedin, G.: On the mechanism of the enhancement by smooth muscle stimulants of the motor responses of the guinea-pig vas deferens to nerve stimulation. Acta physiol. scand. 90, 513–521 (1974)
Slotkin, T.A., Anderson, T.R.: Chronic morphine administration alters epinephrine uptake in rat adrenal storage vesicles. Neuropharmacol. 14, 159–161 (1975)
Smith, A.D., Potter, W.P. de, Moerman, E.J., Schaepdryver, A.F. de: Release of dopamine-β-hydroxylase and chromogranin A upon stimulation of the splenic nerve. Tissue Cell 2, 547–568 (1970)
Smith, A.D., Winkler, H.: Fundamental mechanisms in the release of catecholamines. In: Blaschko, H., Muscholl, E. (eds.), Catecholamines. Handbuch der experimentellen Pharmakologie, Vol. 33, pp. 538–617. Berlin-Heidelberg-New York: Springer 1972
Sorimachi, M., Oesch, F., Thoenen, H.: Effects of colchicine and cytochalasin B on the release of 3H-norepinephrine from guinea-pig atria evoked by high potassium, nicotine and tyramine. Naunyn-Schmiedeberg's Arch. Pharmacol. 276, 1–12 (1973)
Starke, K.: Interactions of angiotensin and cocaine on the output of noradrenaline from isolated rabbit hearts. Naunyn-Schmiedebergs Arch. Pharmakol. 265, 383–386 (1970)
Starke, K.: Influence of α-receptor stimulants on noradrenaline release. Naturwissenschaften 58, 420 (1971a)
Starke, K.: Action of angiotensin on uptake, release and metabolism of 14C-noradrenaline by isolated rabbit hearts. Europ. J. Pharmacol. 14, 112–123 (1971b)
Starke, K.: Alpha sympathomimetic inhibition of adrenergic and cholinergic transmission in the rabbit heart. Naunyn-Schmiedeberg's Arch. Pharmacol. 274, 18–45 (1972a)
Starke, K.: Influence of extracellular noradrenaline on the stimulation-evoked secretion of noradrenaline from sympathetic nerves: Evidence for an α-receptor-mediated feed-back inhibition of noradrenaline release. Naunyn-Schmiedeberg's Arch. Pharmacol. 275, 11–23 (1972b)
Starke, K.: Beziehungen zwischen dem Renin-Angiotensin-System und dem vegetativen Nervensystem. Klin. Wschr. 50, 1069–1081 (1972c)
Starke, K.: Influence of phenylephrine and orciprenaline on the release of noradrenaline. Experientia (Basel) 29, 579–580 (1973a)
Starke, K.: Regulation of catecholamine release: α-Receptor mediated feed-back control in peripheral and central neurones. In: Usdin, E., Snyder, S.H. (eds.), Frontiers in Catecholamine Research, pp. 561–565. New York: Pergamon Press 1973b
Starke, K., Altmann, K.P.: Inhibition of adrenergic neurotransmission by clonidine: An action on prejunctional α-receptors. Neuropharmacol. 12, 339–347 (1973)
Starke, K., Borowski, E., Endo, T.: Preferential blockade of presynaptic α-adrenoceptors by yohimbine. Europ. J. Pharmacol. 34, 385–388 (1975a)
Starke, K., Endo, T., Taube, H.D.: Relative pre-and postsynaptic potencies of α-adrenoceptor agonists in the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch. Pharmacol. 291, 55–78 (1975b)
Starke, K., Endo, T., Taube, H.D., Borowski, E.: Presynaptic receptor systems on noradrenergic nerves. In: Almgren, O., Carlsson, A., Engel, J. (eds.), Chemical Tools in Catecholamine Research, Vol. 2, pp. 193–200. Amsterdam-Oxford: North-Holland 1975c
Starke, K., Görlitz, B.D., Montel, H., Schümann, H.J.: Local α-adrenoceptor mediated feed-back inhibition of Catecholamine release from the adrenal medulla? Experientia (Basel) 30, 1170–1171 (1974a)
Starke, K., Montel, H.: Sympathomimetic inhibition of noradrenaline release: Mediated by prostaglandins? Naunyn-Schmiedeberg's Arch. Pharmacol. 278, 111–116 (1973a)
Starke, K., Montel, H.: Alpha-receptor-mediated modulation of transmitter release from central noradrenergic neurones. Naunyn-Schmiedeberg's Arch. Pharmacol. 279, 53–60 (1973b)
Starke, K., Montel, H.: Interaction between indomethacin, oxymetazoline and phentolamine on the release of (3H)noradrenaline from brain slices. J. Pharm. Pharmacol. 25, 758–759 (1973c)
Starke, K., Montel, H.: Involvement of α-receptors in clonidine-induced inhibition of transmitter release from central monoamine neurones. Neuropharmacol. 12, 1073–1080 (1973d)
Starke, K., Montel, H.: Influence of drugs with affinity for alfa-adrenoceptors on noradrenaline release by potassium and tyramine. In: Proceedings of the 2nd Meeting on Adrenergic Mechanisms, Porto, 1973e, pp. 53–54
Starke, K., Montel, H.: Lokale Rückkopplungssteuerungen der Noradrenalinfreisetzung als mögliche Angriffspunkte antihypertensiver Pharmaka. Therapiewoche 23, 4263–4264 (1973f)
Starke, K., Montel, H.: Influence of drugs with affinity for α-adrenoceptors on noradrenaline release by potassium, tyramine and dimethylphenylpiperazinium. Europ. J. Pharmacol. 27, 273–280 (1974)
Starke, K., Montel, H., Gayk, W., Merker, R.: Comparison of the effects of clonidine on pre-and postsynaptic adrenoceptors in the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch. Pharmacol. 285, 133–150 (1974b)
Starke, K., Montel, H., Schümann, H.J.: Influence of cocaine and phenoxybenzamine on noradrenaline uptake and release. Naunyn-Schmiedebergs Arch. Pharmakol. 270, 210–214 (1971a)
Starke, K., Montel, H., Wagner, J.: Effect of phentolamine on noradrenaline uptake and release. Naunyn-Schmiedebergs Arch. Pharmakol. 271, 181–192 (1971b)
Starke, K., Schümann, H.J.: Interactions of angiotensin, phenoxybenzamine and propranolol on noradrenaline release during sympathetic nerve stimulation. Europ. J. Pharmacol. 18, 27–30 (1972)
Starke, K., Wagner, J., Schümann, H.J.: Adrenergic neuron blockade by clonidine: Comparison with guanethidine and local anesthetics. Arch. int. Pharmacodyn. 195, 291–308 (1972)
Starke, K., Werner, U., Hellerforth, R., Schümann, H.J.: Influence of peptides on the output of noradrenaline from isolated rabbit hearts. Europ. J. Pharmacol. 9, 136–140 (1970)
Starke, K., Werner, U., Schümann, H.J.: Wirkung von Angiotensin auf Funktion und Noradrenalinabgabe isolierter Kaninchenherzen in Ruhe und bei Sympathicusreizung. Naunyn-Schmiedebergs Arch. Pharmakol. 265, 170–186 (1969)
Steinsland, O.S., Furchgott, R.F.: Desensitization of the adrenergic neurons of the isolated rabbit ear artery to nicotinic agonists. J. Pharmacol. exp. Ther. 193, 138–148 (1975)
Steinsland, O.S., Furchgott, R.F., Kirpekar, S.M.: Inhibition of adrenergic neurotransmission by parasympathomimetics in the rabbit ear artery. J. Pharmacol. exp. Ther. 184, 346–356 (1973)
Steinsland, O.S., Nelson, S.H.: “Alpha-adrenergic” inhibition of the response of the isolated rabbit ear artery to brief intermittent sympathetic nerve stimulation. Blood Vessels 12, 378–379 (1975)
Stitzel, R.E., Robinson, R.L., Stevens, P.: Effects of Ba++ and aminophylline on the release of 3H-ATP, ATP and catecholamines from bovine adrenal glands. Fed. Proc. 32, 784 Abs (1973)
Stjärne, L.: Enhancement by indomethacin of cold-induced hypersecretion of noradrenaline in the rat in vivo — by suppression of PGE mediated feed-back control? Acta physiol. scand. 86, 388–397 (1972a)
Stjärne, L.: Prostaglandin E restricting noradrenaline secretion — neural in origin? Acta physiol. scand. 86, 574–576 (1972b)
Stjärne, L.: Alpha-adrenoceptor mediated feed-back control of sympathetic neurotransmitter secretion in guinea-pig vas deferens. Nature New Biol. (Lond.) 241, 190–191 (1973a)
Stjärne, L.: Kinetics of secretion of sympathetic neurotransmitter as a function of external calcium: Mechanism of inhibitory effect of prostaglandin E. Acta physiol. scand. 87, 428–430 (1973b)
Stjärne, L.: Lack of correlation between profiles of transmitter efflux and of muscular contraction in response to nerve stimulation in isolated guinea-pig vas deferens. Acta physiol. scand. 88, 137–144 (1973c)
Stjärne, L.: Uncompetitive character of inhibition by prostaglandin E2 of the enhancing effect of α-adrenoceptor blocking drug on noradrenaline secretion in isolated guinea-pig vas deferens. Acta physiol. scand. 89, 278–282 (1973d)
Stjärne, L.: Michaelis-Menten kinetics of secretion of sympathetic neurotransmitter as a function of external calcium: Effect of graded alpha-adrenoceptor blockade. Naunyn-Schmiedeberg's Arch. Pharmacol. 278, 323–327 (1973e)
Stjärne, L.: Inhibitory effect of prostaglandin E2 on noradrenaline secretion from sympathetic nerves as a function of external calcium. Prostaglandins 3, 105–109 (1973f)
Stjärne, L.: Dual alpha-adrenoceptor mediated control of secretion of sympathetic neurotransmitter: one mechanism dependent and one independent of prostaglandin E. Prostaglandins 3, 111–116 (1973g)
Stjärne, L.: Comparison of secretion of sympathetic neurotransmitter induced by nerve stimulation with that evoked by high potassium, as triggers of dual alpha-adrenoceptor mediated negative feed-back control of noradrenaline secretion. Prostaglandins 3, 421–426 (1973h)
Stjärne, L.: Role of alpha-adrenoceptors in prostaglandin E mediated negative feedback control of the secretion of noradrenaline from the sympathetic nerves of isolated guinea-pig vas deferens. Prostaglandins 4, 845–851 (1973i)
Stjärne, L.: Frequency dependence of dual negative feedback control of secretion of sympathetic neurotransmitter in guinea-pig vas deferens. Brit. J. Pharmacol. 49, 358–360 (1973k)
Stjärne, L.: Prostaglandinversus α-adrenoceptor-mediated control of sympathetic neurotransmitter secretion in guinea-pig isolated vas deferens. Europ. J. Pharmacol. 22, 233–238 (1973l)
Stjärne, L.: Mechanisms of catecholamine secretion. Dual feedback control of sympathetic neuro-transmitter secretion; role of calcium. In: Usdin, E., Snyder, S.H. (eds.). Frontiers in Catecholamine Research, pp. 491–496. New York: Pergamon Press 1973m
Stjärne, L.: Stereoselectivity of presynaptic α-adrenoceptors involved in feedback control of sympathetic neurotransmitter secretion. Acta physiol. scand. 90, 286–288 (1974)
Stjärne, L.: Basic mechanisms and local feedback control of secretion of adrenergic and cholinergic neurotransmitters. In: Iversen, L.L., Iversen, S.D., Snyder, S.H. (eds.): Handbook of Psychopharmacology, Vol. 6, pp. 179–233. New York-London: Plenum Press 1975a
Stjärne, L.: Selectivity for catecholamines of presynaptic alpha-receptors involved in feedback control of sympathetic neurotransmitter secretion in guinea-pig vas deferens. Naunyn-Schmiedeberg's Arch. Pharmacol. 288, 295–303 (1975b)
Stjärne, L.: Pre-and post-junctional receptor-mediated cholinergic interactions with adrenergic transmission in guinea-pig vas deferens. Naunyn-Schmiedeberg's Arch. Pharmacol. 288, 305–310 (1975c)
Stjärne, L.: Clonidine enhances the secretion of sympathetic neurotransmitter from isolated guinea-pig tissues. Acta physiol. scand. 93, 142–144 (1975d)
Stjärne, L.: Rate limiting factors in sympathetic neurotransmitter secretion. Acta physiol. scand. 93, 220–227 (1975e)
Stjärne, L.: Relative importance of calcium and cyclic AMP for noradrenaline secretion from sympathetic nerves of guinea-pig vas deferens and for prostaglandin E-induced depression of noradrenaline secretion. Neurosci. 1, 19–22 (1976)
Stjärne, L., Brundin, J.: Dual adrenoceptor-mediated control of noradrenaline secretion from human vasoconstrictor nerves: Facilitation by β-receptors and inhibition by α-receptors. Acta physiol. scand. 94, 139–141 (1975a)
Stjärne, L., Brundin, J.: Affinity of noradrenaline and dopamine for neural α-receptors mediating negative feedback control of noradrenaline secretion in human vasoconstrictor nerves. Acta physiol. scand. 95, 89–94 (1975b)
Stjärne, L., Gripe, K.: Prostaglandin-dependent and-independent feedback control of noradrenaline secretion in vasoconstrictor nerves of normotensive human subjects. Naunyn-Schmiedeberg's Arch. Pharmacol. 280, 441–446 (1973)
Stjärne, L., Wennmalm, Å.: Quantitative estimation of secretion and reuptake of adrenergic transmitter in the rabbit heart. Acta physiol. scand. 81, 286–288 (1971)
Story, D.F., Allen, G.S., Glover, A.B., Hope, W., McCulloch, M.W., Rand, M.J., Sarantos, C.: Modulation of adrenergic transmission by acetylcholine. Clin. exp. Pharmacol. Physiol., Suppl. 2, 27–33 (1975)
Strait, M.R., Bhatnagar, R.K.: Inhibition of norepinephrine release elicited by nerve stimulation by an analog of apomorphine. Fed. Proc. 34, 740 Abs (1975)
Strömbom, U.: Catecholamine receptor agonists. Effects on motor activity and rate of tyrosine hydroxylation in mouse brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 292, 167–176 (1976)
Struyker Boudier, H., Boer, J. de, Smeets, G., Lien, E.J., Rossum, J. van: Structure activity relationships for central and peripheral alpha adrenergic activities of imidazoline derivatives. Life Sci. 17, 377–385 (1975)
Su, C., Bevan, J.A.: The release of H3-norepinephrine in arterial strips studied by the technique of superfusion and transmural stimulation. J. Pharmacol. exp. Ther. 172, 62–68 (1970a)
Su, C., Bevan, J.A.: Blockade of the nicotine-induced norepinephrine release by cocaine, phenoxy-benzamine and desipramine. J. Pharmacol. exp. Ther. 175, 533–540 (1970b)
Summers, R.J., Blakeley, A.G.H.: The effects of piperoxan (933F) on uptake of noradrenaline and overflow of transmitter in the isolated blood perfused cat spleen. In: Abstr. 6th Int. Congr. Pharmacol., Helsinki, 1975, p. 491
Sutherland, E.W., Robison, G.A., Butcher, R.W.: Some aspects of the biological role of adenosine 3′,5′-monophosphate (cyclic AMP). Circulation 37, 279–306 (1968)
Svensson, T.H., Bunney, B.S., Aghajanian, G.K.: Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine. Brain Res. 92, 291–306 (1975)
Svensson, T.H., Trolin, G.: Brain noradrenaline neurons: Drugs affecting impulse flow, transmitter turnover and blood pressure. In: Almgren, O., Carlsson, A., Engel, J. (eds.), Chemical Tools in Catecholamine Research, Vol. 2, pp. 119–125. Amsterdam-Oxford: North-Holland 1975
Swedin, G.: Studies on neurotransmission mechanisms in the rat and guinea-pig vas deferens. Acta physiol. scand., Suppl. 369 (1971)
Sweet, C.S., Ferrario, C.M., Khosla, M.C., Bumpus, F.M.: Antagonism of peripheral and central effects of angiotensin II by (1-sarcosine, 8-isoleucine)angiotensin II. J. Pharmacol. exp. Ther. 185, 35–41 (1973)
Szerb, J.C.: The effect of morphine on the adrenergic nerves of the isolated guinea-pig jejunum. Brit. J. Pharmacol. 16, 23–31 (1961)
Szerb, J.C.: Lack of effect of morphine in reducing the release of labelled acetylcholine from brain slices stimulated electrically. Europ. J. Pharmacol. 29, 192–194 (1974)
Szerb, J.C., Somogyi, G.T.: Depression of acetylcholine release from cerebral cortical slices by choliaesterase inhibition and by oxotremorine. Nature New Biol. (Lond.) 241, 121–122 (1973)
Taube, H.D., Endo, T., Bangerter, A., Starke, K.: Presynaptic receptor systems on the noradrenergic nerves of the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch. Pharmacol. 293, R2 (1976)
Taube, H.D., Montel, H., Hau, G., Starke, K.: Phencyclidine and ketamine: Comparison with the effect of cocaine on the noradrenergic neurones of the rat brain cortex. Naunyn-Schmiedeberg's Arch. Pharmacol. 291, 47–54 (1975)
Terenius, L., Wahlström, A.: Morphine-like ligand for opiate receptors in human CSF. Life Sci. 16, 1759–1764 (1975)
Teschemacher, H., Opheim, K.E., Cox, B.M., Goldstein, A.: A peptide-like substance from pituitary that acts like morphine. 1. Isolation. Life Sci. 16, 1771–1775 (1975)
Thoa, N.B., Woolen, G.F., Axelrod, J., Kopin, I.J.: On the mechanism of release of norepinephrine from sympathetic nerves induced by depolarizing agents and sympathomimetic drugs. Molec. Pharmacol. 11, 10–18 (1975)
Thoenen, H., Hürlimann, A., Haefely, W.: Dual site of action of phenoxybenzamine in the cat's spleen: Blockade of α-adrenergic receptors and inhibition of re-uptake of neurally released norepinephrine. Experientia (Basel) 20, 272–273 (1964a)
Thoenen, H., Hürlimann, A., Haefely, W.: Wirkungen von Phenoxybenzamin, Phentolamin und Azapetin auf adrenergische Synapsen der Katzenmilz. Helv. physiol. pharmacol. Acta 22, 148–161 (1964b)
Thoenen, H., Hürlimann, A., Haefely, W.: The effect of angiotensin on the response to postganglionic sympathetic stimulation of the cat spleen; lack of facilitation of norepinephrine liberation. Med. Pharmacol. exp. 13, 379–387 (1965)
Thoenen, H., Hüerlimann, A., Haefely, W.: Interaction of phenoxybenzamine with guanethidine and bretylium at the sympathetic nerve endings of the isolated perfused spleen of the cat. J. Pharmacol. exp. Ther. 151, 189–195 (1966a)
Thoenen, H., Tranzer, J.P., Hürlimann, A., Haefely, W.: Untersuchungen zur Frage eines cholinergischen Gliedes in der postganglionären sympathischen Transmission. Helv. physiol. pharmacol. Acta 24, 229–246 (1966b)
Thornburg, J.E., Blake, D.E.: Effects of morphine on 5-hydroxytryptamine uptake by rat brain striatal slices. Fed. Proc. 30, 501 Abs (1971)
Toda, N., Hojo, M., Sakae, K., Usui, H.: Comparison of the relaxing effect of dopamine with that of adenosine, isoproterenol and acetylcholine in isolated canine coronary arteries. Blood Vessels 12, 290–301 (1975)
Tremblay, J.P., Schlapfer, W.T., Woodson, P.B.J., Barondes, S.H.: Morphine and related compounds: Evidence that they decrease available neurotransmitter in Aplysia californica. Brain Res. 81, 107–118 (1974)
Trendelenburg, P.: Physiologische und pharmakologische Versuche über die Dünndarmperistaltik. Arch. exp. Path. Pharmakol. 81, 55–129 (1917)
Trendelenburg, U.: The action of morphine on the superior cervical ganglion and on the nictitating membrane of the cat. Brit. J. Pharmacol. 12, 79–85 (1957)
Trendelenburg, U.: Supersensitivity and subsensitivity to sympathomimetic amines. Pharmacol. Rev. 15, 225–276 (1963)
Trendelenburg, U.: Some aspects of the pharmacology of autonomic ganglion cells. Ergebn. Physiol. 59, 1–85 (1967)
Vanhoutte, P.M.: Inhibition by acetylcholine of adrenergic neurotransmission in vascular smooth muscle. Circulat. Res. 34, 317–326 (1974)
Vanhoutte, P.M., Lorenz, R.R., Tyce, G.M.: Inhibition of norepinephrine-3H release from sympathetic nerve endings in veins by acetylcholine. J. Pharmacol. exp. Ther. 185, 386–394 (1973)
Vanhoutte, P.M., Verbeuren, T.J.: Inhibition of norepinephrine release in vascular smooth muscle by acetylcholine. Due to hyperpolarization of adrenergic nerve endings? Arch. int. Pharmacodyn. 213, 332–333 (1975)
Vargas, O., Miranda, R., Orrego, F.: Effects of sodium-deficient media and of a calcium ionophore (A-23187) on the release of (3H)-noradrenaline, (14C)-α-aminoisobutyrate, and (3H)-γ-aminobuty-rate from superfused slices of rat neocortex. Neurosci. 1, 137–145 (1976)
Vizi, S.E.: The role of Na+-K+-activated ATP-ase in transmitter release: acetylcholine release from basal ganglia and its inhibition by dopamine and noradrenaline. In: Frigyesi, T.L. (ed.), Subcortical Mechanisms and Sensorimotor Activities, pp. 63–87. Bern-Stuttgart-Vienna: Hans Huber 1975
Vizi, S.E., Knoll, J.: The effects of sympathetic nerve stimulation and guanethidine on parasympathetic neuroeffector transmission; the inhibition of acetylcholine release. J. Pharm. Pharmacol. 23, 918–925 (1971)
Vizi, E.S., Rónai, A.Z., Knoll, J.: The inhibitory effect of dopamine on acetylcholine release. Naunyn-Schmiedeberg's Arch. Pharmacol. 285, R89 (1974)
Vizi, E.S., Somogyi, G.T., Hadházy, P., Knoll, J.: Effect of duration and frequency of stimulation on the presynaptic inhibition by α-adrenoceptor stimulation of the adrenergic transmission. Naunyn-Schmiedeberg's Arch. Pharmacol. 280, 79–91 (1973)
Vogel, S.A., Silberstein, S.D., Berv, K.R., Kopin, I.J.: Stimulation-induced release of norepinephrine from rat superior cervical ganglia in vitro. Europ. J. Pharmacol. 20, 308–311 (1972)
Wagner, J., Endoh, M., Reinhardt, D.: Stimulation by phenylephrine of adrenergic alpha-and beta-receptors in the isolated perfused rabbit heart. Naunyn-Schmiedeberg's Arch. Pharmacol. 282, 307–310 (1974)
Waterfield, A.A., Kosterlitz, H.W.: Stereospecific increase by narcotic antagonists of evoked acetyl-choline output in guinea-pig ileum. Life Sci. 16, 1787–1792 (1975)
Wennmalm, Å.: Quantitative evaluation of release and reuptake of adrenergic transmitter in the rabbit heart. Acta physiol. scand. 82, 532–538 (1971)
Wennmalm, Å.: Prostaglandin release and mechanical performance in the isolated rabbit heart during induced changes in the internal environment. Acta physiol. scand. 93, 15–24 (1975)
Wennmalm, Å., Hedqvist, P.: Prostaglandin E1 as inhibitor of the sympathetic neuroeffector system in the rabbit heart. Life Sci. 9, I, 931–937 (1970)
Wennmalm, Å., Hedqvist, P.: Inhibition by prostaglandin E1 of parasympathetic neurotransmission in the rabbit heart. Life Sci. 10, I, 465–470 (1971)
Werner, U., Starke, K., Schümann, H.J.: Wirkungen von Clonidin (ST 155) und BAY a 6781 auf das isolierte Kaninchenherz. Naunyn-Schmiedebergs Arch. Pharmakol. 266, 474–475 (1970)
Werner, U., Starke, K., Schumann, H.J.: Actions of clonidine and 2-(2-methyl-6-ethyl-cyclohexylamino)-2-oxazoline on postganglionic autonomic nerves. Arch. int. Pharmacodyn. 195, 282–290 (1972)
Werner, U., Wagner, J., Schümann, H.J.: Beeinflussung der Noradrenalinabgabe aus isolierten Kaninchenherzen durch β-Adrenolytica unter sympathischer Nervenreizung. Naunyn-Schmiedebergs Arch. Pharmakol. 268, 102–113 (1971)
Westfall, T.C.: Effect of nicotine and other drugs on the release of 3H-norepinephrine and 3H-dopamine from rat brain slices. Neuropharmacol. 13, 693–700 (1974a)
Westfall, T.C.: Effect of muscarinic agonists on the release of 3H-norepinephrine and 3H-dopamine by potassium and electrical stimulation from rat brain slices. Life Sci. 14, 1641–1652 (1974b)
Westfall, T.C., Besson, M.J., Giorguieff, M.F., Glowinski, J.: The role of presynaptic receptors in the release and synthesis of 3H-dopamine by slices of rat striatum. Naunyn-Schmiedeberg's Arch. Pharmacol. 292, 279–287 (1976)
Westfall, T.C., Brasted, M.: The mechanism of action of nicotine on adrenergic neurons in the perfused guinea-pig heart. J. Pharmacol. exp. Ther. 182, 409–418 (1972)
Westfall, T.C., Brasted, M.: Effect of 4,4′-biphenylenebis-[(2-oxoethylene)-bis-(2,2-diethoxyethyl)]dimethylammonium dibromide (DMAE) on accumulation and nicotine-induced release of norepinephrine in the heart. J. Pharmacol. exp. Ther. 184, 198–204 (1973)
Westfall, T.C., Brasted, M.: Specificity of blockade of the nicotine-induced release of 3H-norepinephrine from adrenergic neurons of the guinea-pig heart by various pharmacological agents. J. Pharmacol. exp. Ther. 189, 659–664 (1974)
Westfall, T.C., Hunter, P.E.: Effect of muscarinic agonists on the release of (3H) noradrenaline from the guinea-pig perfused heart. J. Pharm. Pharmacol. 26, 458–460 (1974)
Wooten, G.F., Thoa, N.B., Kopin, I.J., Axelrod, J.: Enhanced release of dopamine β-hydroxylase and norepinephrine from sympathetic nerves by dibutyryl cyclic adenosine 3′,5′-monophosphate and theophylline. Molec. Pharmacol. 9, 178–183 (1973)
Yaksh, T.L., Yamamura, H.I.: Blockade by morphine of acetylcholine release from the caudate nucleus in the mid-pontine pretrigeminal cat. Brain Res. 83, 520–524 (1975)
Yoshizaki, T.: Effect of histamine, bradykinin and morphine on adrenaline release from rat adrenal gland. Jap. J. Pharmacol. 23, 695–699 (1973)
Younkin, S.G.: An analysis of the role of calcium in facilitation at the frog neuromuscular junction. J. Physiol. (Lond.) 237, 1–14 (1974)
Zimmerman, B.G.: Effect of acute sympathectomy on responses to angiotensin and norepinephrine. Circulat. Res. 11, 780–787 (1962)
Zimmerman, B.G.: Blockade of adrenergic potentiating effect of angiotensin by 1-Sar-8-Ala-angiotensin II. J. Pharmacol. exp. Ther. 185, 486–492 (1973)
Zimmerman, B.G., Gisslen, J.: Pattern of renal vasoconstriction and transmitter release during sympathetic stimulation in presence of angiotensin and cocaine. J. Pharmacol. exp. Ther. 163, 320–329 (1968)
Zimmerman, B.G., Gomer, S.K., Liao, J.C.: Action of angiotensin on vascular adrenergic nerve endings: facilitation of norepinephrine release. Fed. Proc. 31, 1344–1350 (1972)
Zimmerman, B.G., Liao, J.C., Gisslen, J.: Effect of phenoxybenzamine and combined administration of iproniazid and tropolone on catecholamine release elicited by renal sympathetic nerve stimulation. J. Pharmacol. exp. Ther. 176, 603–610 (1971)
Zimmerman, B.G., Ryan, M.J., Gomer, S., Kraft, E.: Effect of the prostaglandin synthesis inhibitors indomethacin and eicosa-5,8,11,14-tetraynoic acid on adrenergic responses in dog cutaneous vasculature. J. Pharmacol. exp. Ther. 187, 315–323 (1973)
Zimmerman, B.G., Whitmore, L.: Effect of angiotensin and phenoxybenzamine on release of norepinephrine in vessels during sympathetic nerve stimulation. Int. J. Neuropharmacol. 6, 27–38 (1967)
Zwieten, P.A. van: Antihypertensive drugs with a central action. Progr. Pharmacol. 1, 1–63 (1975)
Rights and permissions
Copyright information
© 1977 Springer-Verlag
About this chapter
Cite this chapter
Starke, K. (1977). Regulation of noradrenaline release by presynaptic receptor systems. In: Reviews of Physiology, Biochemistry and Pharmacology. Reviews of Physiology, Biochemistry and Pharmacology, vol 77. Springer, Berlin, Heidelberg. https://doi.org/10.1007/BFb0050157
Download citation
DOI: https://doi.org/10.1007/BFb0050157
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-07963-7
Online ISBN: 978-3-540-37998-0
eBook Packages: Springer Book Archive